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Like many countries, the Republic of Moldova faces a growing NCD burden. This report examines the challenges 
and opportunities faced in the Republic of Moldova in order to accelerate improvement in NCD outcomes. In 
recent years, the Government of the Republic of Moldova has implemented a number of important reforms that 
have increased effi  ciency and equity in resource allocation, and have provided incentives to improve service 
delivery, including for NCDs. Challenges include further scale up and implementation of new initiatives in 
the area of NCD risk factor management. Major gains can be made through relatively low-cost public health 
and primary health care interventions. These include, among others, strengthening tobacco, alcohol, and 
dietary polices and their implementation, improving detection and treatment of risk factors for cardiovascular 
disease, including hypertension and hyperlipidaemia, strengthening clinical protocols, and improving rational 
prescribing practice. This report examines in depth the health system challenges and opportunities for improved 
prevention and control of NCDs and concludes with policy recommendations for the consideration of policy 
makers in the Republic of Moldova.  
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Introduction and rationale
This country assessment is part of a project of the WHO Regional Offi  ce for Europe to increase 
support to Member States in strengthening their health system to improve noncommunicable 
diseases (NCDs) outcomes. Five countries participated in a fi rst round of assessments: Hungary, 
Kyrgyzstan, the Republic of Moldova, Tajikistan and Turkey. The fi ve country assessments were 
carried out by multidisciplinary teams using a common approach. The assessments were based 
on a structured assessment guide, tailored to the specifi c needs of each country. The guide 
itself was based on a background paper exploring the role of health systems in tackling NCDsa. 
The country assessment had two objectives. First, they aimed to produce pragmatic, 
contextualized and actionable policy recommendations for health system strengthening, 
to allow accelerating gains in key NCD outcomes for Republic of Moldova. The assessments 
and the accompanying policy recommendations are intended to provide a platform for 
a comprehensive NCD action plan to serve as an umbrella for a number of already existing 
sub-sectoral plans. Second, as part of the regional project, the assessments will contribute to 
sharing of knowledge and experiences among the countries of the region on common health 
system barriers to NCD control and promising approaches to overcome them. Early results 
of the assessment were featured in the High-level Meeting on Health Systems for Health 
and Wealth in the Context of Health 2020 in Tallinn, Estonia on 17-18 October 2013; the 10th 
Flagship Course on Health Systems Strengthening in Barcelona, Spain on 21–30 October 2013; 
the International Anniversary Conference Marking 35 Years of the Declaration of Alma-Ata on 
Primary Health Care in Almaty, Kazakhstan on 6-7 November 2013; and the WHO European 
Ministerial Conference on the Prevention and Control of NCDs in the Context of Health 2020 in 
Ashgabat, Turkmenistan on 3–4 December 2013.  
Like many countries, the Republic of Moldova faces a growing NCD burden. NCDs are the 
main causes of mortality and morbidity, and have high priority in both the Moldovan National 
Health Policy for 2007–2021 and the Health Care System Development Strategy for 2008–2017. 
In recent years, the Government of the Republic of Moldova has implemented a number of 
reforms that have increased effi  ciency and equity in resource allocation, and have provided 
incentives to improve service delivery, including for NCDs.
A multidisciplinary expert team visited the Republic of Moldova from 21 to 24 May 2013.The 
team was joined by an expert team from the National health insurance company (CNAM), the 
National Centre of Public Health, the Center of Health Policies and Studies (PAS centre), and 
the State Medical and Pharmaceutical University, led by the Ministry of Health Department of 
Policies Analysis, Monitoring and Evaluation. During the mission, consultations were held with 
a wide range of experts and stakeholders involved in NCD control in the country. Presentations 
and small group discussions provided an opportunity to share information, review data, identify 
successes and challenges, and build consensus around some of the key points in this assessment. 
Individual follow-up meetings took place, as well as fi eld visits to primary health care centres, 
district hospitals, territorial medical associations, the medical university and nongovernmental 
organizations (NGOs). These meetings and visits allowed impressions to be formed fi rst-hand 
and information from documents, discussions and presentations to be compared with the 
situation in practice. Impressions formed were presented to key stakeholders at the end of the 
mission for further consensus-building. The draft report was reviewed and fi nal input gathered 
in a two day policy workshop held 19th-20th of February 2014 with participation of senior MoH 
offi  cials, representatives from nongovernmental organizations and development partners.
This report is presented in fi ve sections. Section 1 outlines trends in key NCD outcomes, with 
a focus on mortality-based indicators. Section 2 assesses the coverage of the core population 
and individual services for NCD control. Section 3 discusses health system opportunities 
and challenges to core NCD interventions and services, while section 4 describes selected 
innovations and good practices in the Republic of Moldova. Section 5 concludes with policy 
recommendations.
7a See Annex 1 for an explanation of the country groupings used throughout this report..
For many of the countries of the former Soviet Union, independence was accompanied by a 
sharp decline in health outcomes. In the early 1990s, many of these countries experienced a 
rise in mortality from noncommunicable diseases (NCDs), such as cardiovascular disease (CVD), 
with rates remaining high until around 2005, when they started to fall (Fig. 1).
Despite the recent downward trend in some 
of the main causes of mortality, there remains 
a signifi cant gap in life expectancy between 
the countries of the former Commonwealth 
of Independent States (CIS) and the EU-
15 countries.a  Over half of this gap can be 
explained by circulatory disease mortality. 
Improvements in cardiovascular outcomes 
were responsible for over half the health 
gains made in the EU-15 in recent decades.2 
Despite impressive progress in health system 
reform, all-cause mortality in the Republic 
of Moldova continues to be high, with 1261 
deaths per 100 000 population in 2012.3 
NCDs are responsible for the majority of this 
mortality (87%). Cardiovascular diseases are 
the leading cause, accounting for 55% of 
all deaths, followed by cancer (14%). Other 
leading causes of mortality include injuries 
(8%), respiratory disease (4%), diabetes (1%), 
and other NCDs (13%), with communicable disease, maternal and child health and nutritional 
conditions accounting for 5%.4 
Since 2005, CVD mortality, the leading cause of mortality in the Republic of Moldova has shown 
a clear downward trend (Fig 2) The same can be seen for respiratory disease. For cancer, the 
second leading cause of death, rates appear to be stagnant, unlike in the CIS countries and the 
EU-12, where all-cancer mortality is declining (Fig. 3).For diabetes no clear downward trend 
can be detected.
1. Noncommunicable disease outcomes
According to the data from the National Institute of Oncology, the most frequently diagnosed 
cancers in women are breast cancer (22.1%), followed by colorectal cancer (11.1%); in men, the 
most common are lung cancer (17.7%) and colorectal cancer (14.2%).
The burden of NCDs in the Republic of Moldova is unevenly distributed, with mortality from 
CVD, cancer and respiratory disease all signifi cantly higher in males than in females (Fig. 4). 
An uneven distribution of mortality can also be seen across the country. For example, cancer 
mortality is higher in many rural districts (Fig. 5). The same is true for several other NCDs.
Mortality from chronic liver disease and cirrhosis in the Republic of Moldova is the highest in 
the WHO European Region, with more than 70 deaths per 100 000. This is 3–7 times higher 
than the rates in the two EU groupings (Fig. 6 and 7). Rates are high throughout the country, 
but highest in the central part. Mortality from chronic liver disease and cirrhosis is often used 
as a proxy measure of a wide range of health problems associated with excessive alcohol 
use.3
8
For the major groups of NCDs associated with high mortality rates, there are four main risk 
factors: tobacco smoking, harmful use of alcohol, physical inactivity and poor diet. Last 
reported data3 indicate that the prevalence of smoking among men in the Republic of 
Moldova is the fourth highest in the WHO European Region. Per capita alcohol consumption 
is the highest in the Region (Fig. 8 and 9).
9
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The global action plan on NCD calls for a 25% reduction in selected outcome indicators by 
2025. Current trends suggest that this target may be feasible for CVDs and respiratory disease 
targets. Major health gains are possible with low-cost interventions at the population and 
individual level, increased coverage of core interventions to support a reduction in tobacco 
and alcohol use, a reduction in salt consumption, increase of physical activity, the treatment 
of risk factors for cardiovascular disease at primary care level and better management of acute 
episodes, such as heart attack and stroke.
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This section explores the coverage of core population interventions (related to tobacco and 
alcohol use and nutrition) and individual services (for prevention and management of CVD, 
diabetes, and cancer) that are closely linked with improving NCD outcomes. The core services 
reviewed are closely linked to the Global and European Action Plans for the Prevention and 
Control of Noncommunicable Diseases 2013–2020. They are evidence-based, high-impact, cost-
eff ective, aff ordable and feasible to implement in a variety of health systems. Each intervention 
and service was reviewed by the assessment team, on a three-point scale, as limited, moderate 
or extensive. Exact criteria for the scoring were developed by WHO and can be found in Annex 2.
2. Coverage of core CVD interventions 
and services
* Indicates interventions and services added to the list in the WHO Global Action plan to allow a more 
comprehensive assessment (WHO, 2013a).
Table 1. Core population interventions and individual services for NCDs*
Core population interventions Core individual services
• Wide range of anti-smoking  interventions 
 –  Raise tobacco taxes to reduce aff ordability
 –  Smoke-free environments 
 –  Warning about the dangers of tobacco 
and tobacco smoke 
 –  Bans on tobacco advertising, promotion 
and sponsorship
• CVD and diabetes – fi rst line  
 – Risk stratifi cation in primary health care, 
including hypertension, cholesterol, diabetes 
and other CVD risk factors  
 – Eff ective detection and management of 
hypertension, cholesterol,  and diabetes 
through multidrug therapy based on risk 
stratifi cation
 – Eff ective prevention in high-risk groups and 
secondary prevention after AMI, including 
acetylsalicylic acid 
• CVD and diabetes – second line  
 – Range of rapid response and secondary care 
interventions after AMI and stroke
• Interventions to prevent harmful alcohol 
use
 – Use pricing policies on alcohol including 
taxes on alcohol
 – Restrictions and bans on alcohol 
advertising and promotion 
 – Restrictions on the availability of alcohol 
in the retail sector
• Diabetes
 – Eff ective detection and general follow-up 
 – Patient education and intensive glucose 
management
 – Hypertension management among diabetes 
patients
 – Prevention of complications (e.g. eye and foot 
examination)
• Interventions to improve diet and physical 
activity
 – Reduce salt intake and salt content
 – Replace trans-fats with unsaturated fat
 – Implement public awareness programmes 
on diet and physical activity
• Cancer – fi rst line
 – Prevention of liver cancer through hepatitis B 
immunization
 – Screening for cervical cancer and treatment 
of precancerous lesions
• Cancer – second line
 – Vaccination against human papilloma virus 
as appropriate if cost-eff ective according to 
national policies
 – Early case-fi nding for breast cancer and 
timely  treatment of all stages
 – Population-based colorectal cancer screening 
at age >50 linked with timely treatment
 – Oral cancer screening in high risk groups 
linked with timely treatment   
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2. 1 Population interventions 
Great opportunities for NCD control exist in the area of population interventions in the Republic 
of Moldova, and taking advantage of them is going to be critical to the success of eff orts to 
address NCDs. The ratifi cation by the Republic of Moldova of the Framework Convention on 
Tobacco Control (FCTC) and the recent national alcohol and tobacco programmes off er an 
important platform, on which a number of actions could be built. 
The Republic of Moldova is a both a producer and an exporter of alcohol and tobacco. Alcohol 
production continues to be a major source of revenue for the Government. The local tobacco 
industry has reduced in size in recent years, as farmers move to more profi table crops, but offi  cial 
export fi gures are still around 900 million cigarettes per year, while overall annual production is 
estimated to be around 4.1 billion cigarettes.
In the national public budget, revenues from tobacco taxes rose from 130 million Lei (€7.1 million) 
in 2008 to about 830 million Lei (€45.5 million) in 2012. However, the taxation rate is still among 
the lowest in the WHO European Region and is lower than in most of the Newly Independent 
States. 
The tobacco legislation has been revised, and the new draft law is fully in line with the provisions 
of the FCTC. It still has to be approved by the Parliament, but could potentially have a signifi cant 
impact on public health and NCD control. 
The current law imposes a partial smoking ban in public buildings and workplaces but there are 
problems with enforcement. The legislation is outdated and includes a number of exceptions, 
especially in the hospitality sector. Some establishments in the hospitality sector have, however, 
introduced smoking bans, mainly by dividing their premises into smoking and non-smoking 
areas, which is not the best protective measure. Warning labels on cigarette packages have been 
introduced, but cover only 30% of the package size. There is a total ban on direct and indirect 
advertising of tobacco products on television and radio, and in written and electronic media; 
however, advertising is still permitted at points of sale and on smoking accessories, such as 
lighters and ash-trays. Cessation services are non-existent, but are expected to be developed 
Tobacco and alcohol
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A healthy diet and lifestyle are important for better control of hypertension, diabetes and 
cardiovascular disease. In 2013, the Ministry of Health initiated in coordination with an 
intersectoral working group the development of a National Food and Nutrition Programme for 
2014–2020. Public consultations will be held before the revised draft programme is tabled for 
government approval. 
Other steps taken include legislation in 2012 prohibiting the preparation, distribution, and sale 
of food considered unhealthy for children in or within 100 meters of educational institutions. 
The Ministry of Health subsequently established a list of foods not recommended for children. 
However, there is no clear enforcement mechanism or penalties for non-conformity. In 2013, the 
Republic of Moldova participated for the fi rst time in the WHO Childhood Obesity Surveillance 
Initiative. Following a year of preparations, a nationwide, population-based survey on risk 
factors for chronic disease was conducted for the fi rst time from October to November 2013. 
Common for all three major intervention areas – alcohol, tobacco and diet/lifestyle – are weak 
enforcement mechanisms, which greatly reduces the impact of legislation. Data collection 
and surveillance of risk factors also seem weak, considering their public health importance. 
Information is mainly collected through Multiple Indicator Cluster Surveys and Demographic 
and Health Surveys (DHS), although steps are being taken to broaden this base.
Table 2 summarizes the assessment team’s evaluation of the core population interventions for 
NCD control.
Diet and healthy lifestyles
as part of the National Tobacco Control Programme 2012–2016. The National Centre of Public 
Health is currently developing counselling and treatment guidelines for health professionals. 
As regards alcohol, there are laws on taxation, advertising and regulation of the availability of 
alcohol in the retail sector, but the legislation has exclusion criteria and enforcement is weak. 
Recent changes in legislation have even liberalized the selling of wine, by exempting it from 
taxation and restrictions on availability. 
In May 2012, the minimum age for buying alcohol was increased from 16 to 18 years. Retailers 
are now obliged to ask buyers to present an identity card or other offi  cial document with a 
photograph. This is not fully enforced, however, and does not cover the sale of alcohol in bars and 
clubs. Sales in grocery stores and other retail points are restricted between 22h00 and 8h00. In 
2012, the minimum price of strong alcohol products (25% proof or more) was further increased. 
There are indications that this may have resulted in reduced production of strong alcohol for the 
domestic market but increased export of strong alcohol products. 
Taxes on alcoholic beverages such as vermouths, fermented beverages (cider, mead, etc.), 
distillates, liqueurs and vodka were recently raised, but not those on beer and related beverages. 
In 2012, a Government decision defi ned beer as an “alcoholic beverage”, although it can still be 
sold anywhere without a licence and without an age limit, and advertising is not restricted. In 
December 2013, the legal level of blood alcohol content for drivers was reduced to 0.3 g/l and the 
punitive measures have been tightened. 
A legal initiative stipulating a total ban on advertising for alcoholic beverages, including beer, 
as well as the reduction of availability of alcohol in the retail sector, is expected to be approved 
by the parliament by the end of 2014. There are no counselling services for alcohol-dependent 
people at primary care level, but these are expected to be developed as part of the National 
Alcohol Control Programme 2012–2020.
Two national campaigns on tobacco and alcohol were carried out by the Ministry of Health in 
collaboration with WHO in 2012 and 2014 respectively. Tailored messages were given through 
television and radio broadcasts, outdoor advertisements, brochures, fl yers and posters, fl ash 
mobs and community events. Various sectors were involved in the communication activities, 
including the police, medical students and residents, public health and primary health care 
centres, Teleradio Moldova and nongovernmental organizations.
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Intervention Score card with commentsa
Anti-smoking  interventions 
Raise tobacco taxes Limited. Tax is less than 25% of retail price (latest data from 2012). 
 Smoke-free environments Limited. Smoking is prohibited only in schools and medical and 
sports institutions.
Warnings of dangers of 
tobacco and smoke  
Moderate. Warning labels on all tobacco products at least 30% of 
package size (front and back).
Bans on advertising, 
promotion, sponsorship
Limited. Ban on national television, radio, mass media and Internet.
Quit-lines and nicotine 
replacement therapy (NRT)
Limited. No quit-lines or Government funded cessation services. NRT 
available, fully paid for by individual.
Interventions to prevent 
harmful alcohol use
Raise taxes on alcohol Limited. Aromatized wines, beer and spirits are taxed, but from 2013 
wine is exempt from tax.
Restrictions, bans on 
advertising/promotion
Limited.  Frameworks exist to regulate content and volume of alcohol 
marketing; there are problems with enforcement.
Restrictions on availability of 
alcohol in retail sector
 Moderate. Regulatory frameworks on serving alcohol in 
governmental institutions and ban on serving alcohol in educational 
institutions.
Minimum purchase age with 
enforcement
Limited. Minimum age of 18 to purchase alcohol products but limited 
enforcement.
Allowed blood alcohol level 
for driving
Limited. Maximum permitted blood alcohol level 0.3 g/litre
Interventions to improve 
diet and physical activity
Reduce salt intake and salt 
content in foods
No data/limited.
Virtually eliminate trans-fatty 
acids from the diet
Limited. There is no evidence that trans-fats have been signifi cantly 
reduced in the diet.
Reduce free sugar intake Limited. The aim to reduce the intake of free sugars is mentioned in 
policy documents but no action has been taken.
Increase intake of fruit and 
vegetables
Limited. The aim to increase consumption of fruits and vegetables is 
mentioned in policy documents, but no specifi c actions have to been 
taken.
Reduce marketing  of food 
and non-alcoholic beverages 
to children
Moderate. Legislation prohibits the preparation, distribution and 
sale of foods considered unhealthy for children in or within 100 m of 
educational institutions. There are no  clear enforcement mechanisms 
or penalties.
Promote awareness about 
diet and physical activity
Not assessed
Table 2. Evaluation of core population interventions for NCD control
a For details of evaluation criteria, see Annex 2.
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The Republic of Moldova has made impressive progress in health system reform in recent 
years. Actions have included prioritizing health resourcing within the state budget, health 
system fi nance reform, prioritizing primary health care, and improving effi  ciency in the area of 
pharmaceuticals. There are now excellent opportunities to build on this basis and strengthen the 
coverage of core individual services for NCD control, including detection and management of 
risk factors, such as hypertension and hyperlipidaemia, and improve management of acute NCD 
events, such as acute myocardial infarction (AMI) and stroke. 
2.2 Individual services
Cardiovascular disease and diabetes
Acute events
While there have been improvements in detection of hypertension at the primary health 
care level, our fi ndings suggest that relatively few patients are offi  cially registered as having 
hypertension. Field visits revealed that approximately 10–12% of assigned patient populations 
are offi  cially registered with hypertension, whereas hypertension prevalence is estimated to be 
possibly as high as 50%.6
Patients with hypertension are routinely stratifi ed according to their risk of CVD complications, 
calculated using the Systematic Coronary Risk Evaluation (SCORE) risk tables. This method 
is recommended in the national clinical protocol on hypertension and doctors receive 
pay incentives for calculating CVD risk through the health insurance company’s pay-for-
performance bonuses.
Patient adherence to long-term antihypertensive treatment is low; research has shown daily 
adherence rates of only 27%1 This is despite the most commonly used antihypertensive and 
oral hypoglyaemic agents being on the CNAM reimbursed drug list and available to insured 
patients at a 50–100% discount. 
Annual screening for diabetes in patients over 45 years, using fasting blood sugar, has become 
routine since its incorporation in the pay-for-performance scheme in January 2013. This and 
other CVD risk factors, with the exception of smoking, are usually documented in health 
records, a practice facilitated by the use of special chart inserts developed at the facility level. 
Data gathered during site visits suggest that clinicians do not routinely base primary prevention 
decisions on CVD risk scores, which results in overtreatment with aspirin and under treatment 
with statins. Treatment with statins tends to be based on cholesterol levels alone, rather than 
overall CVD risk. Even when they are deemed necessary, statins are often not prescribed or 
taken because of their high cost (statins are currently not included in the list of reimbursed 
drugs). Secondary prevention after AMI with aspirin and beta-blockers is routine. 
Diabetes schools for patients exist in family medicine centres and health centres, but their 
eff ectiveness is questionable, as attendance is limited and educational materials are sparse. 
Glucometers are provided to patients with diabetes at no cost, but test strips must be paid for, 
limiting the use of home blood sugar monitoring. 
There is a well functioning emergency response service throughout the country, organized into 
four regional stations, 41 substations, and 85 emergency posts to ensure a coverage radius for 
each post of less than 25 km. There is approximately one ambulance per 10 000 population, but 
emergency medical service (EMS) staffi  ng rates are low, at 56.5%.  Ambulances seen during the 
site visits were well equipped with electrocardiograph (ECG) machines, defi brillators, oxygen, 
oxygen saturation monitors, and glucometers. Patients suspected of having acute coronary 
syndrome (ACS) are given oral nitrates; aspirin is typically given at the hospital.  
There is an excellent health information system used by all ambulance stations, which allows 
detailed analysis of response times and quality of delivered services.  Essential laboratory 
services (including cardiac enzymes), ECG, and plain radiographs are available 24 hours a day 
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Cervical and breast cancer
There is wide variation in access to cancer screening throughout the country, with higher coverage 
in territorial medical associations (Chisinau) and rayons (districts) covered by pilot programmes, 
but limited access and long delays in obtaining cervical cytology results in regions outside the 
capital. 
Offi  cial statistics suggest that, in 2010, 62% of at-risk women were screened with Papanicolaou 
(Pap) smears.  In most territorial health administrations and family medicine centres, nurse-
midwives, rather than family doctors, perform all of the Pap smears. Throughout the country, 
methods used to fi x and stain the smears are not consistent with international standards and 
there is no system in place for external quality control of cervical cytology.
Only four of nine inter-rayon laboratories have cytologists to read Pap smears, resulting in 
overloading of cytology laboratories in Chisinau. Outside of six rayons included in a national 
pilot project to improve cancer screening, women are typically referred to the capital for 
mammography because of outdated equipment at the periphery.
Table 3  summarizes the assessment team’s evaluation of the core individual services for NCD 
control.
at the territorial hospital level. Aspirin, heparin, beta-blockers, and angiotensin-converting 
enzyme (ACE) inhibitors are routinely prescribed to patients with ACS. Thrombolytics are not 
administered at the territorial hospital level for AMI, and mortality rates from AMI are high (30–
35%).b  Non-evidence-based medications (e.g. diphenhydramine, papavarine and Actovegin) 
are frequently prescribed to patients admitted with hypertensive urgencies, ACS or AMI, 
despite the availability of national clinical protocols.
Only about one-third of patients with ACS are admitted through the ambulance service, and 
long delays in seeking care are typical.  A study in 2010 by the emergency service system found 
that 30% of patients with ACS presented within six hours; however, at one territorial hospital, 
of 239 patients admitted with ACS in 2012, no patients were admitted within six hours of onset 
of pain, and only 9% within 24 hours. 
b Statistics obtained from territorial hospitals and ambulance stations during site visits.
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For full score card criteria see the country assessment guide.
cThe assessment found that there is a discrepancy between the MOH regulation(MOH prekaz, May 2013) 
on diabetes screening (over 40) (MOH prekaz, May 2013)and the pay-for-performance indicator used by 
NHIC (over 45)
Service Score card with comments
CVD
Risk stratifi cation in primary 
health care 
Moderate. Patients with hypertension routinely assigned to risk group 
(SCORE method). Most risk factors, except smoking, are documented.
Eff ective detection and 
management of hypertension
Limited. Detection of hypertension is improving, but still low. Low 
levels of continuous use of antihypertensives, with limited eff ort to 
address adherence issues. Branded antihypertensives commonly 
prescribed. 
Eff ective primary prevention 
in high-risk groups   
Limited. Clinicians do not routinely base primary prevention decisions 
on CVD risk scores, resulting in overtreatment with aspirin and under 
treatment with statins.
Eff ective secondary 
prevention after AMI, 
including aspirin
Moderate. Aspirin and beta-blockers routinely prescribed after acute 
myocardial infarction. Low level of statin use.
Rapid response and hospital 
for AMI and stroke
Limited. Ambulance service is well organized and functioning well, 
but patients often present late (low population awareness). Some 
essential services at central rayon hospital level (acetylsalicylic acid, 
beta-blockers, ACE inhibitors, heparin), but thrombolytics are not 
used. Non-evidence-based drugs are frequently prescribed. The 
management model for stroke is outdated.
Diabetes
Eff ective detection and 
general follow-up (additional 
criteria not in Global Action 
Plan)
Limited. No evidence-based systematic method to select patients 
for screening (screening all patients over age 40).c Only about 2.5% of 
population registered as having diabetes.
Patient education on 
nutrition, physical activity 
and glucose management
Moderate. Diabetes schools exist, but attendance is limited, especially 
in rural areas and curriculum not standardized. Glucometers are 
provided free of cost, but not test strips. Glycaeted haemoglobin 
(HbA1C) tests can be ordered by endocrinologist only; less than 75% 
had a HbA1C test in past year.
Hypertension management 
among patients with diabetes
Not assessed
Preventing complications Not assessed
Cancer
Hepatitis B immunization Extensive. Extensive coverage with routine immunization against 
hepatitis B (>95% coverage).
Cervical cancer screening and 
treatment of lesions
Limited. Signifi cant urban/rural gap, with lower levels of screening 
(overall 60%) and long delays in receiving results (up to 3 months) 
in rural areas. Collection and processing methods not in line with 
international standards. No external quality assurance of cytology.
Early case-fi nding for breast 
cancer and treatment of all 
stages
Limited. Signifi cant urban/rural gap. Limited coverage by 
mammography outside pilot studies. Quality control questionable.
Table 3 Evaluation of core individual services for NCD control
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To deliver the core services outlined in section 2, the Moldovan health system needs to perform 
distinctive tasks on primary and secondary prevention, disease management, and treatment of 
acute events. This section reviews the health system features that infl uence performance of these 
tasks (Fig. 11).
Fig. 11. Fifteen health system challenges and opportunities to improve NCD outcomes
Political commitment and support to the NCD agenda have an important infl uence on NCD control. 
Translation of this commitment into action to keep NCDs high on the agenda for what are often 
politically diffi  cult reforms (e.g. anti-tobacco policies, reform of medical education) is critical. In the 
Republic of Moldova, two main documents outline the overarching policy framework for health 
while health is seen as a cross cutting issue the national development strategy – Moldova 2020. 
The Moldovan National Health Policy 2007–2021 is an overarching document specifying 
the role of all sectors in safeguarding the health of the population. NCD control is well 
covered in this document, which includes specifi c chapters on tobacco and alcohol, nutrition and 
healthy lifestyles, and noncommunicable disease, including CVD, diabetes, cancers and chronic 
obstructive pulmonary disease (COPD). The document also includes more general chapters 
highlighting the important role of health promotion and disease prevention. The document is 
declarative in nature, and does not provide a clear indicator framework. 
The newly approved “Moldova 2020” outlines an overarching development strategy for the 
country. It does not have a particular section on health, which is seen as a cross-cutting area, 
and health is not covered under the existing priority areas. The document does have chapters on 
roads, education, fi nance, business development, energy, pension and the justice system. 
Source: Roberts MJ, Stevenson MA. Improving outcomes for noncommunicable diseases through health 
system strengthening. Copenhagen: WHO Regional Offi  ce for Europe, 2014 (forthcoming)
3.1 Developing political commitment to better NCD 
control
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In every health system, priorities need to be set to determine the allocation of scarce resources. How 
this process is organized, including the level of transparency and criteria for prioritization, is an 
important health system feature infl uencing NCD control. 
In the Republic of Moldova, health expenditure as a percentage of the state budget has 
remained fairly stable and is among the highest of the CIS countries, ranging between 
12.5% and 12.8% over the past 5 years.
The Ministry of Health is in charge of planning and executing the state budget in the health 
sector. Once the overall budget has been approved by Parliament, the Ministry can reallocate 
the resources according to current priorities or emerging needs.
The Republic of Moldova has prioritized primary health care, allocating between 25% and 
30% of public health expenditure to PHC. Only 2.3–3.3% of overall health expenditure 
goes to public health, and the proportion is even decreasing (Table 4). 
In line with policy commitments, the Republic of Moldova has started to address the major 
risk factors for NCDs. In 2012, two national programmes were launched, related to alcohol and 
tobacco control, respectively. The Parliament has also approved an NCD strategy, and a related 
plan of action is under development. Importantly, the Republic of Moldova has ratifi ed the 
Framework Convention on Tobacco Control. These are important steps and it is vital to continue 
on this path in order to reduce mortality from major NCDs.
At the health sector level, the Republic of Moldova has adopted the Health Care System 
Development Strategy 2008–2017. This Strategy follows the health system framework described 
by WHO  and is accompanied by an action plan and a monitoring framework. The context for the 
Strategy development and implementation is summarized in the quote below, which highlights 
the key focus on strengthening quality and effi  ciency of the health care system.
“Over the last years Republic of Moldova has registered signifi cant progress in reforming its 
healthcare system. The fi rst phase of the reform process was oriented towards stopping the decline 
in the healthcare system conditioned by the fi nancial crisis over the last decade of the previous 
century. The second phase was marked to a great extent by the introduction of the mandatory health 
insurance which was accompanied by a signifi cant increase of system funding, improvement of the 
fi nancial protection of the population and its access to healthcare services. The next phase provides 
for the mobilization of all resources for structural changes that would result in increased effi  ciency 
and quality of the healthcare system.”   
Moldovan Health Care System Development Strategy 2008-2017
 The Health Care System Development Strategy highlights the increasing burden of NCD and 
focuses on systems aspects of NCD control, including the need for a strong public health system.
“The consumption of alcohol and tobacco are also signifi cant risk factors that determine the 
epidemiologic profi le of the country due to the fact that these practices are closely connected with 
many chronic diseases, such as the diseases of the circulatory system, malignant neoplasms, and 
especially, diseases of the liver.”  
Moldovan Health Care System Development Strategy 2008-2017
The document also highlights the need for an integrated information system and the importance 
of strengthening evidence-based medicine and accreditation of facilities. Several of the priority 
actions mentioned in the document have already been implemented, including the introduction 
of clinical protocols and the adoption of Good Manufacturing Practice (GMP) standards for 
pharmaceuticals.  
In line with policy commitments, the Republic of Moldova has started to address the major 
risk factors for NCDs. In 2012, two national programmes were launched, related to alcohol and 
tobacco control, respectively. The Parliament has also approved an NCD strategy, and a related 
plan of action is under development. Importantly, the Republic of Moldova has ratifi ed the 
3.2 Creating explicit processes for setting priorities 
and limits
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Framework Convention on Tobacco Control. These are important steps and it is vital to continue 
on this path in order to reduce mortality from major NCDs. 
Our assessment could not identify a clear process for determining the allocation of 
resources between public health and individual services. This carries the risk that funding 
may be allocated to demanding aspects of individual service delivery at the expense of cost-
eff ective public health measures that will, in the long term, reduce the pressure on individual 
services. NCD mortality and morbidity cannot be reduced without a strong focus on population-
based risk factor control.
Further work is needed to strengthen public health services for NCD control. Although 
legislation on public health was enacted in 2009, progress has been slow and fi nancing continues 
to be low. CNAM co-fi nances public health programmes on tobacco and alcohol. A prevention 
fund has been established, and contained 35.9 million Lei in 2013. The funds are divided between 
reducing risk of disease, e.g. cancer screening (32.2 million Lei (90%) in 2013) and promoting 
healthy lifestyles, e.g. public health measures to reduce alcohol and tobacco use  (3.7 million 
Lei (10%) in 2013). In 2011, for example, the Ministry of Health and CNAM organized a public 
prevention campaign, and brochures and information materials were also produced for the 
districts. 
The CNAM health insurance fund covers 82% of the population; coverage of the 18%, 
remaining uninsured is reportedly to an extent related to high rates of economic migration. 
The basic benefi t package (BBP) includes primary health care, in patient services, specialist care, 
palliative care, CVD, diabetes, COPD, and some cancer and emergency care. Of the individual core 
services listed in table 4 most are covered with the exception of cholesterol-lowering statins and 
some of the second-line treatment for stroke and myocardial infarction.
BBP coverage of the population has been strengthened in recent years. Since 2010, there is 
universal coverage of primary health care and emergency services. Payment mechanisms are in 
place that improve equity in resource allocation and provide incentives for health care providers 
to deliver better services. Since 2013, additional incentives have been introduced through 
a “pay-for-performance” mechanism to improve the screening and management of core 
NCDs at primary care level. 
Financial coverage remains a challenge. Out-of-pocket expenditures are high, at over 45% of 
total health expenditure in 2011 , and are largely driven by outpatient drug expenditure (see 
section 3.10). 
The resource allocation process is not entirely clear, particularly when resources are insuffi  cient. 
In most instances, rationing of services seems to be done de facto rather than as a result of a 
transparent priority-setting process.
The Republic of Moldova has a policy on palliative care and a comprehensive regulatory 
framework to cover these services (see section 4).
2008 2009 2010 2011 2012
Health expenditure as % of total state 
budgeta 12.6 12.6 12.8 12.8
National health budget (public) (million Lei) 3391.3 3846.8 3996.5 4261.1 4590.6
Public health budget as % of total health 
budgetb 3.2 3.3 3.2 2.3 2.38
Public health budget (million Lei) 109.5 127.9 128.9 104.1 109.2
a Source of data: Ministry of Finance.
b Source of data: Ministry of Health, unpublished mission report (Republic of Moldova graduating from 
GAVI support: situation analysis and transposition plan) 2012.
Table 4. Health expenditure in the Republic of Moldova, 2008–2012
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The success of NCD control is highly infl uenced by the level of government commitment to health in 
general, and how well this translates to multisectoral action in areas such as tobacco, alcohol, diet 
and healthy lifestyles. 
The major NCDs have common risk factors. The high prevalence of these risk factors in the 
Republic of Moldova means that intersectoral action is very important for eff ective NCD 
control. The ratifi cation of the FCTC by the Republic of Moldova has set the stage for greatly 
strengthening tobacco control. In 2012, two multi-stakeholder committees were set up, on 
alcohol and tobacco, respectively. Both have broad representation from relevant government 
sectors and nongovernmental parties, and are chaired by the Deputy Prime Minister. The 
enabling factors for eff ective collaboration across sectors include: national leadership from the 
highest level (Deputy Prime Minister or similar); a well articulated, jointly owned plan of action, 
with clear division of tasks, and benchmarks or progress indicators; clear coordination and review 
mechanisms to discuss progress; and, ideally, joint funding. 
In the case of tobacco, the coordination committee mechanism is explicitly linked to the 
implementation of a tobacco control programme, while at the time of writing this is not 
yet the case for the alcohol committee, which was established in late 2013. Developing 
an eff ective link to an implementation programme, monitoring and reviewing progress, and 
increasing the proportion of funding that is shared or coordinated will be important for both 
tobacco and alcohol. 
An intersectoral coordination committee has recently been set up to develop a national 
programme on diet and healthy lifestyles. 
In all three areas, the enforcement modalities are unclear, which greatly reduces the 
potential impact of legislation. Eff ective enforcement requires good intersectoral collaboration 
and a high priority at national level. 
Many NCDs are chronic in nature, which means that citizen empowerment and the active 
involvement of patients in the management of their condition are essential for NCD control.
Diabetes and hypertension clubs or “schools” have been started in primary health 
care facilities throughout the country; they are a positive innovation and should be 
developed further. In these schools, patients participate in a series of lessons, typically led by 
a cardiologist, endocrinologist, or family doctor, covering topics such as lifestyle modifi cation, 
medical management, and the importance of adherence to treatment. Doctors receive pay-for-
performance points, based on the number of patients who participate.
Patient attendance and engagement in these schools is highly variable, and there is no 
standardized educational package. There are no particular system incentives for patients to 
participate in the schools (e.g. reduced prices for drugs). To date, there has been no evaluation 
of the impact of these schools on patient behaviour or on blood pressure control. CNAM has 
funded the production of materials, including on cessation of tobacco smoking, but these are 
not systematically integrated in the schools and do not appear to be part of a defi ned package 
of educational and promotional materials. 
Patients with myocardial infarction or stroke tend to present late for hospital care. This 
may be because of low awareness among the population of the warning symptoms of these 
acute events and the benefi t of early treatment. Another possible explanation is perceived or 
real fi nancial barriers to treatment. The results of a study on access to care showed that 33% 
of patients did not access health care when needed, 20% of whom cited unaff ordability of 
services as the reason.  
3.3 Strengthening interagency cooperation
3.4 Enhancing population empowerment
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The organization of service delivery remains one of the most important health system features for 
NCD control. Despite decades of eff orts, health systems in many countries remain hospital-centred 
and specialist-driven. Yet, the delivery of core services requires strong primary health care with a broad 
task profi le.  Ideally, primary health care would provide core services for NCD patients, with handover 
to specialized care levels for acute and complex events, and an engaged and proactive re-transfer to 
the primary level for disease management. Eff ective primary health care is also central to peer-to-peer 
patient education programmes, support groups and health promotion outreach activities. Primary 
health care needs to become the hub of care, with empowered patients as frontline workers and with 
information technology facilitating coordination and transfer of information. 
The balance between primary care and hospital care is at the core of service delivery 
reforms in the Republic of Moldova. The model of primary health care, as outlined in current 
regulatory documents, is reasonable. Patients are assigned to a primary care provider, but have 
the option of enrolling with a diff erent provider of their choice no more than once a year. Patients 
are expected to see their primary care provider for non-emergencies, and can then be referred, if 
necessary, either to a specialist as outpatients or to a hospital. For patients referred by a primary 
care provider to a specialist, the consultation and associated diagnostic testing should be free of 
charge. Patients who seek care directly from a specialist without referral are required to pay for 
all services.
Facilities are typically open on weekdays from 08h00 to 17h00 and at least half a day on Saturdays. 
An appointment system is working well in the territorial medical associations (TMAs) in Chisinau, 
but outside the capital patients are seen on a fi rst-come, fi rst-served basis. Most health centres 
have introduced nurse check-in rooms; patients are expected fi rst to register and get their 
ambulatory record, and then to go to the nurse check-in room, where blood pressure, pulse, 
and heart rate are routinely measured. However, many established patients bypass this check-in 
process and go straight to their doctor. 
The system of chronic disease management introduced during Soviet times (the dispensary 
system) is still partially followed, in that patients with certain chronic illnesses are offi  cially 
registered in a journal. However, content of care is now governed primarily by recommendations 
and standards listed in the clinical protocols.
Problems in the current model of service delivery include the following.
• In many cases, the gatekeeper role of primary health care providers is being bypassed. 
A study in 2010 showed that up to 45% of patients seek care directly from a specialist,7 while 
a survey in 2012 indicated that 22% of rural and 29% of urban patients go to a specialist 
fi rst for new health problems.12
• There is an over-reliance on specialists to manage patients with uncomplicated NCDs, 
such as hypertension and type 2 diabetes. Although most family doctors feel confi dent to 
diagnose and manage hypertension, the national clinical protocol obliges them to refer 
patients to a cardiologist for confi rmation of diagnosis, management recommendations 
and routine consultation at least once a year. Referral to a specialist is also obligatory for 
diabetes and asthma, for confi rmation of diagnosis and routine follow-up. However, family 
doctors feel less confi dent about their ability to diagnose and manage these illnesses 
independently. Glycosylated haemoglobin tests can be ordered only by endocrinologists, 
which also promotes over-reliance on specialists; all family doctors should be familiar with 
the use of this test for both diagnosis of diabetes and management of glycaemic control.
3.5 Establishing eff ective models of service delivery
Nurses and community workers could be better used to strengthen health promotion and 
prevention of NCDs. For example, nurses and mid-level health workers could take on a greater 
role in risk factor control (e.g. hypertension) and  promotion of good practice in preventing 
diabetes complications. 
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3.6 Improving coordination across providers
3.7 Taking advantage of economies of scale and 
specialization
• Although nurse check-in rooms exist in most primary health care facilities, only a small 
percentage of patients go through this examination before seeing the doctor. Checking 
and documenting vital signs then becomes the physician’s responsibility, which may be 
contributing to the low hypertension detection rates. 
• Almost all primary health care facilities focus on screening for hypertension only in patients 
over 40 years.
• The ratio of retrained to fully trained family physicians is very high, with up to 80% of doctors 
in primary health care centres having gone through only a 4–6 month retraining.
• Mid-level providers are not used to their full potential. Nurses do not take an active role 
in educating patients during clinic visits or in leading educational sessions in schools for 
patients with diabetes and hypertension. Whenever possible, specialists lead these schools. 
• A Pap smear once every two years for all women of reproductive age, as currently 
recommended, may not be the best approach to cervical cancer screening in the current 
model of care, where not all family doctors perform Pap smears and there is a shortage of 
cytologists.
Unlike the treatment of a one-off infection, care for patients with NCDs typically involves 
coordination among multiple providers. Primary care physicians treating chronic NCD patients 
need to be able to refer them to specialists when complications develop. They also need to 
collaborate with non-physician partners (e.g. health educators, dieticians, physiotherapists) if 
they are to provide optimal care, whether before or after acute events. 
Primary health care providers in the Republic of Moldova typically see coordination of patient care 
as their role, rather than that of a specialist. Communication between primary care providers and 
specialists working with outpatients is typically good, as they work from the same ambulatory 
health record, which contains the results of all tests. 
There is no formal mechanism for primary health care workers to provide a general health 
summary or make specifi c consultation requests to specialists or hospital providers. The standard 
referral forms are mostly for recording biographical rather than clinical data. Because all notes are 
handwritten, it is not uncommon for providers to have diffi  culty reading each other’s clinic notes.
Hospital discharge summaries typically contain key hospital data, fi nal diagnoses, and 
recommendations; however, it is not uncommon for there to be delays in primary care workers 
receiving hospital discharge summaries, especially if follow-up is geographically distant from the 
hospital site. 
As indicated in section 3.5, studies have shown that up to 45% of patients may seek specialist care 
fi rst, which causes the system for coordination and referrals to break down.
When it comes to management of acute events connected to chronic NCDs, or cancer care, some 
health care systems support too many institutions performing highly complex procedures. There 
are two disadvantages to this. One is connected to what economists call “economies of scale”, 
whereby the average cost of a unit of output is lower in a large-volume facility than a small-
volume one. The second aspect is related to the well demonstrated relationship between volume 
and outcome; centres that deal with a large number of cases have significantly better outcomes 
than those with small numbers. 
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3.8 Creating the right incentive systems
The health fi nancing system, including the payment mechanisms in primary care, outpatient 
specialist and hospital levels, are important determinants of quality and effi  ciency in the health 
system. 
General health care fi nancing reforms began in the Republic of Moldova in 2004; they included the 
start of the national health insurance company, (CNAM established by law in 2002 and operational 
in 2004) and the introduction of new methods of fi nancing, providing more autonomy to hospitals 
and improving access.  In 2010, health care coverage was expanded with primary health care and 
emergency outpatient services being made available for the whole population, whether insured 
or not. Payment mechanisms in place improve equity in health resource allocation and provide 
incentives for health care providers to deliver better services. Since 2013, additional incentives 
have been introduced through a pay-for-performance mechanism to improve screening and 
management of core NCD diseases in primary care. CNAM allocates resources to local NGOs to 
provide palliative care for patients with selected diseases, including cancer. The Ministry of Health 
has a specialist who facilitates communication between primary health care and communities, 
but there are limited fi nancial incentives and resources (e.g. educational materials) for patient 
education and counseling about NCD risk factors and behavior change. 
The Republic of Moldova is in the process of reviewing and defining the administrative 
and technical roles for district (rayon), regional and central levels. In particular, the 
regional level needs clearer definition. This will affect all sectors, including health 
service delivery. 
The contributions of the three levels are not well defined for NCD control. As a result, 
all 34 rayons have some level of service, but there is considerable variation depending on 
the availability of specialists and infrastructure. A hospital reform plan has been drafted that 
foresees centralizing selected secondary services to between three and seven centres, with 
the remainder of the rayons having a more general portfolio of services. For AMI and stroke, 
the focus has been on strengthening emergency services, including ambulance services, 
and defining and strengthening referral mechanisms. Improvements have been made in the 
ambulance system, with investments in both equipment and staff. In 2012, the Ministry of 
Health initiated a process of decentralization and regionalization of chemotherapy services. 
The aim is to bring chemotherapy services closer to the patients, by creating two departments 
in the North (Balti) and South (Cahul) regions in addition to currently existing services at 
the Institute of Oncology in the capital city. A feasibility study for the regionalization of 
chemotherapy services was conducted in 2012–13 with World Bank support, and submitted 
to the Ministry of Health for a final decision. 
Decisions about centralization versus decentralization of services must take a number 
of factors into consideration, including: the volume of the service to be delivered (e.g. 
cervical cancer screening is high-volume, while interventions for AMI would be lower); the 
cost and technical expertise required to deliver the service (e.g. administering thrombolytics 
is not technically demanding or high-cost, whereas coronary angiography and stenting 
are); the availability of human resources (e.g. forming stroke teams for inter-rayon or rayon 
hospitals would be nearly impossible in the current environment); and the feasibility of 
transporting patients to higher levels of care where technical services can be provided.
Current clinical protocols do not contain clear referral recommendations reflecting 
regionalization of service delivery based on the above criteria.   This results in some 
patients being managed at regional levels, but not getting the services they need (e.g. 
thrombolytics) and others receiving decentralized services of insufficient quality (e.g. 
cervical cytology without quality assurance or mammography performed by inexperienced 
radiologists using outdated equipment).
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The Republic of Moldova has given priority to the development and fi nancing of primary 
health care. Expenditure on primary health care has accounted for 25–30% of the total health 
budget in recent years (26% in 2013). Expenditure on drugs provided to outpatients is less than 
4% of the total health budget (or 14% of the primary health care budget in 2013). A capitation 
payment scheme for primary care is in place. Currently, capitation payment bands are defi ned 
according to three age groups: children under 5 years; children and adults aged 5–49 years, and 
adults above 50 years. 
The capitation model could be refi ned on the basis of an examination of use of primary 
health care services by age group and sex. Studies in the countries of Central Asia and several 
regions of the Russian Federation have demonstrated that the population between 20 and 49 
years of age rarely seeks primary care. Importantly, men attend almost 50% less than women. 
The peak of hospitalizations for both men and women (excluding for childbirth) occurs in the age 
group 40–65 years. Circulatory system diseases are the most important reason for hospitalization 
among both men and women. If the situation in the Republic of Moldova is similar, consideration 
should be given to including additional incentives to family physicians to give more attention to 
this group.
In 2012, the Republic of Moldova introduced a full pay-for-performance system. This 
is additional to the basic system of per capita funding. Overall 85% of the budget of primary 
health care providers is based on capitation, while an extra 15% can be obtained by carrying out 
certain interventions as specifi ed in a menu of indicators. A total of 22 indicators have been set 
for 2013 against which the payment is made, including nine indicators to improve screening and 
management of NCD (hypertension, diabetes and cervical cancer) (see Table 6).
This is an important step in the right direction. Over time, it will be important to determine 
further the most appropriate mix of payment mechanisms, including the size of payment, 
frequency and set of indicators. 
The pay-for-performance indicators are mainly aimed at monitoring the process of interventions. 
This is good but in the long term it may be necessary to include indicators that refl ect the totality 
 Table 5 Health expenditure in the Republic of Moldova, 2008–2012
Table 6
Maintenance of public spending on health is at an adequate level. During the last 5 years 
expenditures on health amounted to no less than 5% of GDP and at least 12% of total state 
expenditures (Table 5). 
2009 2010 2011 2012 2013
Public Health Expenditures as% of GDP (6.4) 5.6 5.2 5.4 5.1
Public Health Expenditures as% of Total 
State Budget 12.6 12.6 12.8 12.8 12.5
Condition Indicators 
CVD/ 
hypertension
No. of people over 18 years diagnosed for the fi rst time with hypertension
No. of people registered as receiving treatment for hypertension
No. of people trained in hypertension schools
No. of people with SCORE risk chart done
Cervical cancer No. of people over 25 years who have had a gynaecological examination and Pap 
smear
No. of people with confi rmed early stage malignancy (microscopic stage 1, 
macroscopic 1–2)
Diabetes No. of people over 45 years with glucose measured for the fi rst time
No. of people with diabetes treated by family doctor in accordance with protocol
No. of people with diabetes confi rmed and trained in diabetes schools. 
Primary health care
Data Source: Ministry of Finance
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of action or impact achieved, for example percentage of women in a specifi c age group screened 
during the past year. So far, there does not appear to be a strong link at the provider level 
between incentives provided by the scheme and the management of quality in health facilities. 
The introduction of incentive payments based on performance results at the level of primary 
health care is a good start, but can be further strengthened.
The current model assumes monthly performance reviews and payments. It may be worth 
examining the extent to which the values of the indicators can change in such a short period of 
time. There is also a need to determine the frequency and criteria for revision of indicators and 
targets. 
There are currently no electronic records in primary care or hospitals, and registers of chronic 
patients do not exist. All data on the 22 indicators is therefore collected manually in the facilities. 
The aggregate information is entered monthly into the CNAM electronic module. The process 
does not preclude duplication of information and requires additional administrative time to 
obtain, verify and validate the data both at primary care level and in CNAM. At the current stage, 
it may make sense to continue to monitor the established indicators within the internal process 
of quality improvement but reduce the number of indicators that are accepted for payment 
within the pay-for-performance scheme.
Experience from other countries indicates that establishing a registry of chronic patients 
and maintaining electronic registers in pay for performance schemes can be very helpful in 
expanding coverage and is a strong incentive for the development of information systems 
at the primary health care level. CNAM could consider including such indicators into the pay-
for-performance scheme. This would require the creation of standardized national registers 
Feedback indicated that primary health care providers often do not understand the outpatient 
drug programme. CNAM presents the providers with a list of drugs and the total amount of 
compensation,  but the providers do not fully understand the criteria used for setting the amount 
of compensation or how many prescriptions they can write. There are also no clear requirements 
for the management of chronic disease registers and monitoring of prescriptions, and the 
population generally does not understand how co-payments work. 
In addition to fi nancial incentives, creating a monitoring system for primary health care, using the 
existing information systems, may be considered. The discharged (treated) patient database 
could be an eff ective tool for monitoring and indirect evaluation of performance, with 
follow-on management solutions to improve the effi  ciency of primary care. 
 
Expenditure on hospital care accounts for 50% of the total health budget. A system of co-
payments is in place that provides incentives for patients to go fi rst to a primary health 
care provider rather than directly to a hospital. The transition from input-based to output-
based fi nancing mechanisms has included the introduction of a diagnosis-related group (DRG) 
system for hospital payment. 
The DRG system is still under development and several opportunities exist to increase the 
analytical value of the information in the DRG database, including for NCD control. The DRG 
database has personalized information for each treated patient, including standard information 
about the patient (sex, age, address, status, etc.) and standard clinical and statistical information 
(diagnosis, type of surgery, treatment outcome, etc.).
It will be important to continue to develop the DRG system, including defi ning development 
phases and criteria for each phase, and to introduce a system to monitor hospital performance.
There may also be a need to review and possibly revise the approved tariff s for speciality 
outpatient, diagnostic and hospital care for the non-insured population, analysing how the 
established tariff s refl ect the actual cost of health care (or reimbursement rates paid by CNAM). If 
the established tariff s for non-insured patients are lower than those under the mandatory health 
insurance, the population will obviously see more advantage in paying directly for services rather 
than buying a health insurance policy. 
Hospitals
Demand-side incentives 
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There appear to be limited direct incentives to strengthen the public health and demand 
side for healthier lifestyles, including reducing tobacco and alcohol use and improving 
diet. Currently there are limited resources for population-based initiatives. Both CNAM and the 
Ministry of Health have plans for work in this area but there is no common vision and priorities 
are not coordinated, so the work is rather fragmented. As mentioned earlier, there are no specifi c 
incentives to promote attendance at diabetes and hypertension schools. 
Over the past 30 years, a number of studies have demonstrated that physicians’ patterns of 
practice vary greatly. Many physicians do not follow evidence-based guidelines for clinical practice, 
including for key NCDs. Strengthening evidence-based medicine is therefore an important health 
system challenge for NCD control.
The Republic of Moldova has made good progress in integrating evidence-based 
recommendations on priority NCDs into practice. This has been done through the development 
of evidence-based clinical practice guidelines, followed by a multipronged implementation 
scheme, which includes routine integration of guidelines into undergraduate and postgraduate 
curricula, and use of implementation indicators to promote internal audits and links to pay-for-
performance schemes (see also section 4).
The Unit of Health Services Performance and Quality within the Ministry of Health takes the lead 
in this. The Unit aims to improve the quality of health care through standardization of provided 
services, coordination and approval of evaluation and accreditation standards, and ensuring 
patient safety standards. The Unit may play an important role in the integration of evidence into 
practice in future, but currently has very limited capacities (only two staff  members) and needs 
to be strengthened.  
Interviews with physician educators suggest that the quality of training in evidence-based 
medicine (EBM) at undergraduate level could be improved, as the majority of medical school 
graduates have only a limited understanding of basic biostatistics, study design, and evidence 
grading methods. This will require a great deal of eff ort beyond simply introducing a course on 
biostatistics. EBM must become the language of clinical educators throughout training.
A strategic decision was made to adapt international clinical guidelines as abbreviated clinical 
protocols. This certainly has advantages, but does not familiarize practicing clinicians with 
clinical recommendations that are graded and linked to evidence that is also stratifi ed by level 
or strength. Using a strict, comprehensive clinical guideline development methodology, such 
as the Appraisal of Guidelines for Research and Evaluation (AGREE) Instrument (http://www.
agreetrust.org/), would ensure that guideline developers openly state any potential confl ict of 
interest, conduct a balanced assessment of available literature, invite key stakeholders to be 
part of the guideline development team, etc.
An evidence-based medicine approach should also be extended to the development of 
policies aff ecting service delivery, such as the content of Ministry of Health orders, pay-for-
performance schemes, and policies on reimbursement of medicines.
Management of human resources in the health sector, including recruitment and retention of 
health workers, their education, geographical distribution and skill mix, is an important health 
system feature infl uencing NCD control. 
The Republic of Moldova faces human resource problems that are common to many 
countries, including a lack of skilled staff  in rural areas and emigration of health care 
workers that is outpacing the infl ow of trained health workers. In 2008, of 554 medical 
3.9 Integrating evidence into practice
3.10 Addressing human resource challenges
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An important health system feature for NCD control is access to quality medicines. Patients with 
chronic conditions have to take the appropriate medicines on a regular basis and often for their 
entire life. This requires the presence of well-functioning health and supply systems, rational selection, 
prescribing, dispensing and use, aff ordable prices and sustainable fi nancing13.
The Moldovan pharmaceutical system has several positive features but also some 
challenges. Positive factors include the introduction in 2005 of a list of specifi c drugs that are 
reimbursed, a very high proportion of generic drugs registered and the introduction of good 
manufacturing practices (GMP). Challenges include high out-of-pocket payments for medicines, 
suboptimal availability of essential medicines, irrational prescribing and dispensing, not always 
clear and not always evidence-based criteria for including drugs in the reimbursement list. Unless 
these challenges are addressed, particularly the issue of rational prescribing of medicines, it will 
be diffi  cult to improve access to quality medicines for patients.
In 2005, one year after the introduction of national public health insurance, the fi rst 
reimbursement list for outpatient drugs was introduced. The list currently contains a number 
of drugs used in NCD, including 17 drugs for cardiovascular conditions, seven drugs for diabetes 
(including three human insulins), six drugs for respiratory conditions and one immunomodulating 
drug. All cancer drugs are delivered in hospital and are therefore not included in the outpatient 
reimbursement list. In 2011, 32 drugs for cancer treatment were procured for inpatient use in 
2012d.
There is a very high percentage of generic (both brandede,14,15 and non-branded generic) 
drugs registered in the Republic of Moldova (93-94% of all drugs registered in 2011). Indeed, 
a number of branded drugs are not even registered if there is a generic alternative available. 
Prescribing using international non-proprietary names (INNs)f was introduced in late 2012, which 
should, in theory, help increase the proportion of non-generic drugs vs. branded generic and 
3.11 Access to quality medicines for NCDs
school graduates, only 116 found employment in the health sector and, of these, only six in 
rural areas.8 According to a recent study,7 the total number of physicians decreased from 16 
000 to 10 000 between 1990 and 2010, a reduction of almost 40%. The ratio of retrained to 
fully trained family doctors is still very high, with fi ndings from fi eld visits indicating that up to 
80% of family doctors in some primary health care centres are former internists (“therapists”) 
and paediatricians who have gone through a 4–6 month retraining. In addition, the health 
care workforce is ageing—the average age of family doctors is 49 years.12 Encouragingly, many 
medical school graduates seem to be choosing family medicine, with a full class of over 70 
residents this year. 
Besides the numbers and distribution of health workers, it is important that health worker’s 
knowledge and competencies are well correlated with health system needs and desired models 
of care. Given the shortage of specialists in rural areas, it is essential that family doctors are 
trained to diagnose and manage patients with common NCDs, including type 2 diabetes 
and asthma. In addition, family doctors should be capable of managing asymptomatic 
severe hypertension, and initiating multidrug therapy for primary prevention in 
patients at very high risk of CVD complications and for secondary prevention after acute 
myocardial infarction.
Taking into account projections that the number of family doctors will decrease further, 
it is essential to consider strengthening the knowledge and skills of mid-level providers. 
There are user-friendly, algorithm-based protocols for diagnosis and management of 
hypertension that would be appropriate for use by feldshers and nurses.
A joint World Bank/WHO assessment of human resources for health in the Republic of Moldova 
will be published later this year and should be valuable in informing further policy decisions.
d   Based on analysis of national tender data 
e A branded generic is a generic version of the branded originator produced by the manufacturer of the 
originator product14. The commercial distinction between branded and unbranded generic product is 
that the former aims to create brand awareness and, possibly, attract a price premium15.
f  Also called generic prescribing
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branded originator dispensed and reduce drug spending for both CNAM and patients. In practice, 
doctors often give patients a second piece of paper with the commercial name of the drug they 
should request at the pharmacy thus undermining the purpose of introducing INN prescribing. 
As part of recent reforms in the public pharmaceutical sector, public procurement of insulin was 
moved from a vertical programme to the reimbursement list in May 2013 and compliance with 
GMP has been made a requirement to obtain public reimbursement (see section 4). 
There is limited evidence on rational prescribing, dispensing and use of medicines. One 
studyg on rational prescribing found that prescribing of essential medicines increased from 
58.2% in 2004 to 65.2% in 201216. At the same time, polypharmacy, defi ned as more than three 
drugs per prescription, increased during the same time period from 4.5% to 8.5%16. There are no 
studies on dispensing practices. However, the presence of fi nancial disincentives for pharmacies 
to dispense the lowest cost generic drug, their profi ts are based on fi xed margins of drugs’ prices, 
and to over-dispense in the case of minor ailments (e.g. seasonal fl u), suggest that this is an area 
requiring attention. Household budget surveys have documented a decrease in the proportion 
of over-the-counter medicines consumed (from 45.2% in 2010 to 31.4% in 2012) and an increase 
in consumption of prescription medicines (from 52.0% in 2008 to 68.6% in 2012). This suggests 
that people are increasingly seeking professional advice rather than relying on self-treatment, 
thereby potentially reducing the irrational use of medicines (if doctors follow good prescribing 
practices, which, however, does not seem to be the case). 
One possible reason for the increase in seeking a doctor’s advice could be better information 
about drug reimbursement (for which a prescription is needed), which increased from 69.9% in 
2008 to 77.2% in 201217. In 2008, people living in urban areas were better informed regarding 
compensated medicines (74.2%) than those living in rural areas (66.7%)17.  
Overall drug consumption decreased by 11.4% pointsh between 2008 and 201217, however 
because of lack of data on rational vs. irrational use it is not possible to draw defi nitive conclusions 
whether this was a result of a decrease in irrational drug use or decreased access. Increased public-
sector reimbursement for medicines between 2008 and 2012 makes it unlikely that this decrease 
in consumption was due to reduced access, but does not exclude it.
There is strong anecdotal evidence that doctors’ prescribing behaviour is heavily infl uenced 
by pharmaceutical sales representatives. However, there are limited eff orts to improve rational 
selection, prescribing and use of medicines.
1. The payment the hospital receives from diagnostic-related groups (which are meant to 
cover inpatient medicines) is often not suffi  cient to pay for the required medicines and 
therefore some expensive medicine are not procured. 
2. The patient may need a medicine that is not included in clinical protocols and therefore not 
procured. This is particularly the case for new and expensive drugs, and was confi rmed by 
a patient with type 1 diabetes, who reported having to purchase an expensive drug (about 
US$ 500) for the treatment of renal complications. Two situations are likely, in the fi rst, the 
drug is needed but not procured because expensive, in the second case the new and more 
expensive drug is not really needed, a cheaper older generic drug could achieve the same 
result, but because of infl uence from industry, doctors may still recommend this drug. 
3. Stock-outs when medicines supply agreements are signed with winning bidders with 
major delays 
4. Medicines available in the hospital pharmacy may have low eff ectiveness. This occurs only 
in a minority of cases but such cases were reported. 
g This study was based on analysis of prescriptions from a small non-randomised sample of pharmacies. This 
study did not include drugs part of the reimbursement list because by law they need to be prescribed one 
drug per prescription. Despite limitations in the methods, this study is the only available evidence to date 
and sheds some light on prescribing practices.
h Survey participants were asked whether they consumed any medicines in the four weeks preceding the 
survey. In 2008, 44.1% of the survey participants reported having consumed medicines at least once while 
in 2012 this fi gure went down to 32.7%.
30
i For individual medicines, availability refers to the percentage (%) of outlets where an individual medicine 
product was found. For a basket of medicines, availability refers to the mean (average) % availability across 
a basket of medicines.
This is supported by evidence from a national survey in 2011 reporting that 52.5% of the 
patients interviewed received all the medicines they needed at the hospital, while 16.9% 
had to buy them and 29.6% received only some of them and had to buy remain ones19.
A pricing and availability survey20 in 2011 found that the average availability of a basket of 19 NCD 
drugs was highest for lowest-cost generic drugs in the private sector (66%i, n[sample size]=19) 
and lowest for branded drugs in the public sector (22%, n=6 because only six of the 19 medicines 
had a brand drug registered in the country). Since all the drugs were out of patent, the greater 
availability of lowest-cost generic drugs and the low availability of branded drugs is a 
positive fi nding. Availability was higher in the private sector than in the public sector for all drug 
types (29% vs. 22% for branded drugs, 55% vs. 50% for the most-sold generics, 66% vs. 61% for 
the lowest-cost generics).
For all drugs (NCD and non-NCD), the average availability was highest in the private sector in 
urban areas (72% for lowest-cost generics, 62% for most-sold generics and 38% for branded 
medicines) and lowest in the public sector in rural areas (31% for lowest-cost generics, 21% for 
most-sold generics and 5% for branded medicines)20. 
Insulin shortages have been reported by both patient representatives and doctors. Possible 
reasons include incomplete data on the number of patients requiring insulin and distribution 
problems; in particular, lack of an eff ective system to monitor levels of stocks. The high number 
of tests required by the quality control system can also sometimes cause delays in supply21.
The change in the procurement of insulin from a national tender programme to purchase by 
pharmacies is expected to help preventing stock-outs due to better forecasting.
Using methodology developed by WHO and Health Action International (HAI)22, the aff ordability 
of treating a selection of chronic conditions was assessed by comparing the median cost of 
medicine treatment using standard regimens with the minimum daily wage of public sector 
workers (20 Lei or approximately US$ 1.70). Costs were adjusted to take account of the percentage 
reimbursed by CNAM, if applicable. Aff ordability is expressed as the number of days a person on 
the minimum wage would need to work to purchase a month’s supply of medicine to treat a 
chronic condition. Medicines for chronic diseases costing more than one day of wages for a 30-
day supply are generally considered unaff ordable22.
Based on data from the WHO/HAI survey in 2011, results suggest that verapamil, simvastatin 
and hydrochlorothiazide are currently unaff ordable, requiring at least 4.59, 6.5 and 1.21 
days of the minimum wage to purchase a month of treatment. This presents an important 
barrier to CVD control. A more extended analysis of aff ordability by income quintiles is presented 
in Appendix 4.
The criteria for inclusion of medicines in the reimbursement list are not fully clear and 
evidence-based. The national essential medicines list (EML) is currently being updated (the current 
list was just copied from the model WHO list without adaptation to the country epidemiological 
profi le). This is an important step in the right direction and the EML should be used as a basis 
for inclusion in the reimbursement list and linked with national treatment protocols. The 
lack of clear and written evidence-based criteria for inclusion in the list (which is supposed to be 
based on burden of disease and need) has repercussions on the drugs included, some of which 
do not have a strong evidence base. Examples include ambroxol, repaglinide (rather than the 
older and cheaper oral sulfonylureas which are equally eff ective except in patients with poor renal 
function) and salbutamol syrup (which is less eff ective than a metered dose inhaler with spacer/
mask for bronchodilation and has signifi cantly more side-eff ects). Some basic NCD drugs with a 
strong evidence base are missing from the reimbursement list; examples are statins, ipratroprium 
Availability of medicines in the public and private sector
Aff ordability
Reimbursement list
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3.12 Strengthening health systems management
bromide inhaler and furosemide (removed in 2013). Further, no clear justifi cation has been found 
for the reduction in reimbursement of a number of drugs in the latest list (May 2013) and the 
withdrawal of various drugs previously on the list. 
There seem to be rather limited initiatives to reduce outpatient drug prices. The existing 
price monitoring system monitors a sample of most sold drugsj. However, it is unclear the 
extent to which this data is used to inform policy. There is a need to revise price regulations 
for reimbursed medicines and to introduce new measures to obtain better value for money. 
These could include the introduction of a clawback systemk,23,24 diff erential mark-ups and a 
tendering system for selected outpatient drugs25. Currently, CNAM does not benefi t of discounts 
pharmacists receive from wholesalers. The introduction of a clawback system would allow CNAM 
to recoup some of the savings accrued along the supply chain due to off  price list discount. As 
part of a diff erential mark-up system, lower mark-ups could be charged for drugs reimbursed by 
CNAM. Implementation of regressive mark-upsl could also be considered. Currently, pharmacies 
are paid a fi xed mark-up for each drug package dispensed, which provides an incentive to 
dispense more expensive drugs. Introduction of regressive mark-up structure and a dispensing 
fee, which remunerates pharmacists for their services rather than the price of drug dispensed, 
could help generate savings and address some of the problems relating to irrational drug use. 
Introduction of an incentive system to encourage dispensing of non-branded generics could be 
also considered. A tendering system is in place for inpatient medicines but not for outpatients 
ones. Given the small size of the market, it would be worth trying whether using a tendering 
system for the procurement of selected reimbursed outpatient drugs associated with high levels 
of consumption, can lower prices. This would benefi t not only CNAM but also patients in terms 
of lower copayments (patients pay a certain fi xed percentage of a maximum reimbursable price). 
A number of health system challenges (medicine supply issues, poor information systems, lack of 
coordination among providers) refl ect the fact that, at both the institutional and the system level, 
many health systems require better management.
In the Republic of Moldova outside Chisinau, health facility administrators are responsible to local 
government, which runs district hospitals and submits statistical reports to the National Centre 
of Health Management.  Directors of health facilities are selected on a competitive basis by a 
commission at the Ministry of Health in agreement with local authorities. Traditionally, the 
management team in a health facility includes a deputy director for clinical work, heads of 
departments and administrative staff . Staff  for these positions are selected at the facility 
level. Directors of health facilities must attend a general management course before 
assuming their offi  cial duties. The rest of the management team undergoes management 
training sessions in the framework of postgraduate training courses. Management training 
is generally provided by the State University of Medicine and Pharmacy.
Health facilities have a high level of autonomy. The facilities have fi nancial independence and 
their own bank account, and manage their own budget within limits established by a contract 
with CNAM (for example, no more than 60% of the budget can be used for salaries). Managers 
of health facilities have the right to hire and fi re staff , set the rules, assesses staff  performance 
and implement incentive payments. Financial management is traditionally carried out by the 
accounting offi  ce; the primary focus is on accounting, spending and interaction with the fi nancial 
authorities, rather than on strategic planning, analysis of costs or effi  ciencies. Cost accounting is 
not part of the usual management process at facility level. The procedure for providing health care 
is established in accordance with the profi le of the facility. Clinical and management personnel 
develop specifi c procedures to implement clinical practice guidelines and monitor performance 
indicators, as specifi ed by the contract (number of visits, hospitalizations, etc.), but these actions 
are not integrated in a single concept or quality management process.
j  This list includes 50 most sold medicines in 2005, 57% of these medicines are EML (Based on the 18th WHO 
EML, April 2013)
k A clawback system allows health payers to recoup some of the savings accrued along the supply chain due 
to off  price list discount.
l A tiered mark-up structure where more expensive drugs are associated with lower mark-ups.
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3.13 Creating adequate information solutions
There are no clear performance criteria by which health facility administrators are routinely 
assessed (management of managers) apart from the facility accreditation, which is done 
once every fi ve years.  Health statistics are published annually by the National Centre of Health 
Management, which allows certain health outcomes to be compared at district level; however, 
the health statistics are not broken down to the facility level. Health administrators do not work 
towards clinical benchmarks and are not responsible for drawing up action plans to improve 
performance indicators.
Information systems are not generally used for management decision-making. In most 
cases, even where electronic systems or registers are in place, the data from these systems 
are used for external reporting rather than for internal management. Internal quality 
audits are now routinely conducted in primary health care facilities in order to submit pay-
for-performance data; however, beyond this, it is not common for facilities to set goals based 
on internal performance assessments or to track their own performance indicators (either for 
content or organization of services). Many facilities have systems in place for assessing patient 
satisfaction, but they are usually passive (receiving patient complaints) rather than active. To 
a large extent, the success of facilities depends on the personal qualities of the directors and 
management staff , and not on the established systems and procedures. 
Many national health systems have weak information systems, which is both a cause and a 
consequence of managerial weakness. This impedes performance management and monitoring at 
all levels. Information is needed on both quality of care and costs.  
The reforms currently under way in the health system of the Republic of Moldova necessitate new 
standards for the quality, reliability and effi  ciency of medical information. The Ministry of Health 
should intensify work to create a unifi ed health information system linking collection, analysis, 
use and dissemination of data, facilitated by a modern e-health system. 
The diff erent levels of the health system currently use a variety of local information systems 
that are not integrated and do not have uniform standards. In many cases, for each specifi c 
task (reporting form, indicators, etc.) a separate software product is used that is not integrated 
with other modules of the information system. As a result, each local system performs specifi c 
tasks for the health facility, health authority or CNAM. However, the full range of available clinical, 
statistical and fi nancial information is not used for management decision-making at every level 
of the health system. 
Positive examples of information systems in the country are the database of medical emergencies 
(ambulance calls) and the system of electronic registration of discharged patients treated in the 
hospitals, which was implemented throughout the country in 2013. So far, electronic forms are 
rarely used for registration and management of patients. The Ministry of Health and CNAM plan to 
address these issues in 2014, by introducing information systems in primary health care facilities. 
Another positive development is the introduction of a national system of identity numbers 
covering the whole population, which provides an important basis for strengthening information 
systems. Plans are also in place to strengthen e-health and Internet coverage is high. 
The main problems of the existing information system, as a whole and specifi cally for NCD, are as 
follows.
• There is fragmentation and duplication of information in local systems, which limit 
the use of the information system for strategic planning, health care purchasing, and 
monitoring of access to and quality of health services, including for NCDs. The administrative 
costs of maintaining the information system as a whole are also higher than necessary.
• There is limited electronic recording of information or interconnectivity.
• The standard ambulatory health record does not contain health summaries or 
fl ow sheets, which would contribute to the assessment of NCD risk factors. Time-
consuming searches through visit notes are required to fi nd essential information, such 
33
The Moldovan National Bureau of Statistics (NBS) conducts regular household budget 
surveys (HBS). On the basis of the survey data, NBS and the Ministry of Health, with support 
from the World Bank, prepare reports on “Access of the population to the health services”. 
The data allow analysis of barriers to access to care, quality of care, and fi nancial burden for 
patients, disaggregated by socioeconomic status and sex. The survey data also provide general 
information on prevalence of chronic diseases, including NCD. The latest report, from 2012, 
includes data on tobacco consumption, but no data on other NCD risk factors, such as obesity, 
alcohol use or salt intake. A number of additional studies published in recent years provide 
complementary information on access to services, barriers and fi nancial burden for patients. 
Information from the Ministry of Health and recently published studies indicate that the 
availability of health services is good in general, with some geographical and urban/rural 
inequities. Most people have physical access to primary health care facilities within 5 km and less 
than one hour’s travel away. There are some issues related to physical access of the rural population 
to laboratory and diagnostic tests, pharmaceuticals in rural pharmacies and a shortage of primary 
care physicians in rural areas, with a continuing oversupply of specialists in Chisinau.
Overall, fi nancial access improved with the introduction of legislation on health insurance in 
2002, which became fully operational in 2004. Health expenditure as a percentage of the state 
budget is stable and at an appropriate level; coverage of basic health services, regardless of health 
insurance, was expanded in 2009, and additional outpatient drug benefi ts have been introduced. 
Although good progress has been made towards more equal access to care, household 
expenditure on health remains comparatively high; in 2012, health was the fourth-highest 
household expenditure item  at 6%, (Fig 12) after food (43%), household maintenance (19%) and 
clothes and footwear (11%). 
In all areas, overcoming obstacles requires changes in the way health care organizations function. 
All organizations are resistant to change and the management of change is therefore an important 
challenge for the health system in NCD prevention and control.
The Government of the Republic of Moldova has demonstrated commitment and support to 
health care reform. Funding has been kept at a stable level, important health fi nance and service 
delivery reforms have been carried out, primary health care has been given priority, effi  ciency 
measures have been introduced in the pharmaceutical sector and, most recently, national 
programmes on tobacco and alcohol control have been adopted.
Given the diffi  cult political situation in the country and possible changes in the law on the state 
budget and local fi nance, which may lead to changes in the level of funding, the Ministry of 
Health and CNAM need to develop proposals for continued prioritization of health care fi nancing 
and to carry out advocacy at all levels.
For NCD control, it will be essential to strengthen public health and intersectoral cooperation 
in implementing the national tobacco and alcohol control programmes. Specifi c policies and 
interventions are also needed to improve diet, increase physical activity, reduce salt intake, 
replace trans-fats with polyunsaturated fat, and promote public awareness about diet and 
physical activities. Strengthening intersectoral cooperation is probably the most important 
area for change management and the Government needs to consider ways to address this. 
as smoking status, alcohol use, screening results, and even blood pressure. Many facilities 
have designed their own fl ow sheets to summarize the risk factors required for pay-for-
performance reporting and this is likely to have a positive eff ect on the management of 
chronic NCDs. Disease-specifi c fl ow sheets, which serve as reminders of periodic screening 
requirements and summaries of essential fi ndings, are also not used.
3.14 Overcoming resistance to change
3.15 Ensuring access to care and reducing fi nancial 
burden
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Table 7 summarizes the level of OOP payments in the Republic of Moldova. About 50% of all 
expenditure on health is based on private expenditure and about 80% of private expenditure is 
covered by the population. Spending on drugs is the main driver of OOP expenditure.
A recent report8 noted that, while fi nancial protection has improved in the past decade, serious 
challenges persist. Out-of-pocket and informal payments are almost universal and have not 
decreased following the introduction of health insurance. A cross-country comparative study in 
2010 reported that almost all patients (96.3%) had to make OOP payments in various forms.26 The 
size of the OOP payments was in direct relationship to a household’s fi nancial capacity – those 
in the highest income quintile spent, on average, 8.3 times more on health than those in the 
lowest quintile. Most OOP payments are for pharmaceuticals, as public funding covers only 28% 
of expenditure in this category.
 Fig. 12. Public and household expenditure on health, 2000-2012
Table 7. Average health expenditure covered directly by population, by area of residence, 
2008–2012
2008 2010 2012
Total Urban Rural Total Urban Rural Total Urban Rural
Total monthly 
health expenditure 
per person (lei)
Distribution (%)
Primary health 
care 
Drug procurement 
Hospital care 
Transport  
94.1
15.8
64.4
9.9
9.9
100.2
19.4
68.3
7.5
4.8
89.6
12.9
61.2
11.8
14.1
93.6
14.1
63.6
13.7
8.6
100.2
16.3
65.3
13.1
5.4
89.0
12.4
62.4
14.2
11.1
107.7
19.8
62.0
10.6
7.7
103.3
19.8
60.8
14.6
4.8
111.0
19.8
62.8
7.8
9.7
Source: National Bureau of Statistics.
Data source: NBS http://www.statistica.md/category.php?l=en&idc=198&
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Since 2008, 147 clinical protocols have been developed in the Republic of Moldova, including 
on priority NCDs, such as hypertension, diabetes, hyperlipidaemia, asthma, and COPD.  The 
Unit of Health Services Performance and Quality within the Ministry of Health is responsible for 
coordinating the prioritization of topics, creation of working groups, and development of the 
protocols. A national methodology has been approved for developing clinical protocols. While 
other former Soviet countries are also developing national clinical protocols, the Republic of 
Moldova is a leader in establishing a process to facilitate their implementation, with the following 
features.
1. Mandatory inclusion of implementation indicators in the clinical protocol. These indicators 
are already being used by national quality monitoring teams to assess implementation of 
the guidelines at the health facility level. The indicators can also be used by CNAM for their 
external quality assurance reviews and incorporated into pay-for-performance schemes. 
The indicators can also be used for internal audits as part of quality improvement, although 
such audits are not routinely conducted in Moldovan health facilities.
2. Mandatory inclusion of patient education, information and communication materials. 
Educating patients and the general population on the services they should receive for 
diff erent conditions is one way to promote implementation of clinical guidelines, and has 
been shown to be particularly eff ective in improving screening rates. In addition, publishing 
patient education materials in clinical guidelines can facilitate and standardize physician- 
or nurse-directed counselling of patients.
3. Linking of pay-for-performance schemes to health priorities and clinical protocols. Although 
implementation started only recently, health care managers spoke optimistically about 
an increase in provider motivation to adhere to standards as a result of the current pay-
for-performance scheme. Linking pay-for-performance to indicators included in clinical 
protocols and which are, in turn, linked to evidence-based standards of care and desired 
outcomes is a progressive initiative.
There have been a number of positive developments in the Moldovan pharmaceutical sector 
over the past decade. These include: increased funding for public reimbursement of outpatient 
drugs (2004–12); introduction of external reference pricingm (2010); inclusion of insulin in the 
list of reimbursed drugs (2013); increased availability of drugs to treat cancer (2007–12); priority 
to reimbursement of drugs produced according to GMP (2013); and introduction of mandatory 
generic prescribing (2012).
Outpatient sector
A list of reimbursed drugs was fi rst introduced in 2005 and included eight drugs. All insured 
patients are eligible for coverage. The list was updated in 2008, 2009, 2010, 2011 and 2013. The 
current list contains 81 drugs and covers more than ten therapeutic areas (at ATC-1 level), as 
shown in Fig. 13.
Further, all Moldovan citizens are entitled to free access to anti-diabetes, anticonvulsant and 
psychotropic drugs (included in the reimbursement list but reimbursed for everyone, not just 
patients insured by CNAM). There are also various national programmes, co-funded by donors 
and the state, for the procurement of drugs for management of human immunodefi ciency virus 
(HIV) infection, tuberculosis,  some rare diseases (e.g. myasthenia gravis, cystic fi brosis) and for 
palliative care, to which every citizen has access.
4.1 Implementation of national clinical protocols
4.2. Innovations in the pharmaceutical sector
4. Innovations and good practises
m External/International reference pricing is known as manufacturer price registration in the Republic 
Moldova.
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The increased budget has translated into a greater number of drugs being included in the 
reimbursement list over time (Fig. 14), an increased number of reimbursed prescriptions, and an 
increase in the proportion of total prescription value reimbursed per prescription.
 Fig. 13. Number of drugs reimbursed, by ATC group, reimbursement level and benefi ciaries, 2013
Table 8. Available budget and actual expenditure (thousands Lei) on national health insurance and 
outpatient medicines
Notes: Anatomical therapeutic chemical (ATC) group: ATC-A: alimentary tract and metabolism; ATC-B: 
blood and blood-forming organs; ATC-C: cardiovascular system; ATC-H: systemic hormonal preparations, 
excluding sex hormones and insulins; ATC-J: anti-infectives for systemic use; ATC-L: antineoplastic and 
immuno-modulating agents; ATC-N: nervous system; ATC-P: antiparasitic products, insecticides and 
repellants; ATC-R: respiratory system; ATC-S: sensory organs; mix: diff erent ATC-groups.
NA: not available. 
*The planned budget was subsequently increased to cover the additional spending.  
Source: CNAM.
Further, all Moldovan citizens are entitled to free access to anti-diabetes, anticonvulsant and 
psychotropic drugs (included in the reimbursement list but reimbursed for everyone, not just 
patients insured by CNAM). There are also various national programmes, co-funded by donors 
and the state, for the procurement of drugs for management of human immunodefi ciency virus 
(HIV) infection, tuberculosis,  some rare diseases (e.g. myasthenia gravis, cystic fi brosis) and for 
palliative care, to which every citizen has access.
2004 2006 2008 2010 2012
CNAM
CNAM available 
budget
Actual expenditure
1 070 680
1 070 680
1 527 712
1 527 712
2 693 562
2 693 562
3 434 400
3 434 400
3 927 715*
3 984 715
Outpatient 
medicines
Available budget 
for outpatient 
medicines
Actual expenditure 
NA 
7404 (2005)
36 600
23 815
60 404
55 291
116 850
116 849
162 600
166 244
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Fig. 14. Drugs included in the reimbursement list by therapeutic area, 2008-13
Notes: Anatomical therapeutic chemical (ATC) group: ATC-A: alimentary tract and metabolism; ATC-B: 
blood and blood-forming organs; ATC-C: cardiovascular system; ATC-H: systemic hormonal preparations, 
excluding sex hormones and insulins; ATC-J: anti-infectives for systemic use; ATC-L: antineoplastic and 
immuno-modulating agents; ATC-N: nervous system; ATC-P: antiparasitic products, insecticides and 
repellants; ATC-R: respiratory system; ATC-S: sensory organs; mix: diff erent ATC-groups.
Between 2007 and 2011, the number of reimbursed prescriptionsn nearly doubled from 
1 644 088 to 3 212 71427. For reimbursed medicines, by law, one prescription can only list one drug 
suggesting that there was an important increase in the number of medicines reimbursed. The 
average cost per prescription increased from 47.1 Lei in 2007 to 68.6 Lei in 20112727. In parallel, 
the average reimbursement per prescription increased from 24.9 Lei (52.9% of the prescription 
value) to 47.8 Lei (69.7% of the prescription value) between 2007 and 201127.
Until May 2013 insulin was procured through a national tender programme. With the release of 
the new reimbursement list, the most commonly prescribed types of insulino will be procured 
by pharmacies and reimbursed by CNAM (Government funding will be transferred to CNAM).p 
This move – from a national tender programme to decentralized procurement by pharmacies 
– is expected to have several positive eff ects: more reliable supply, as pharmacies will be able 
to adjust their order on the basis of what they dispense; increased choice of insulin types; 
greater availability of insulin across the country; and shorter travel times for patients (insulin was 
previously available only in the main referral primary health care centre in each rayon). However, 
there are also some potential threats, such as the prescribing of newer, more expensive – but not 
more eff ective – types of branded insulin. 
Inpatient sector
Between 2007 and 2012, the number of both anti-neoplastic drugs and doses procured 
increased, meaning that a wider selection of therapies and greater quantity of medicines 
were available to treat cancer patients. This was possible as a result of increased overall 
spending on inpatient medicines over time. Between 2004 and 2012, expenditure on inpatient 
medicines increased substantially from 94 234 000 Lei (US$ 7 898 910) to 357 766 000 Lei (US$ 29 
746 902).q
Regulation 
Until 2013 compliance with GMP was not enforced. Since the release of the latest reimbursement 
list, medicines registered in the European Union, Australia, Canada, Japan or the USA – and 
n  Paper prescriptions written by doctors.
o Only three type of insulin (Insulinum glarginum  100 UI/ml 3 ml, Insulinum detemirum 100 UI/ml 3 ml, Insulinum 
aspartum 100 UI/ml 3 ml) still will be purchased via national tender.
p  All patients, with or without insurance, will still have access to insulin. 
q  Based on data provided by CNAM.
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r It is not specifi ed whether compliance is needed with national GMP or those of WHO, the European 
Medicines Agency (EMA) or the Food and Drug Agency of the USA (FDA), except for psychotropic and 
tuberculosis medicines, for which GMP certifi cation according to either WHO, EMA or FDA is required.
therefore compliant with GMP – are given preferred supplier status. This is expected to provide 
a strong incentive to the local manufacturing industry to improve their manufacturing 
practices according to internationally accepted standards of good quality. For drugs 
registered in the Republic of Moldova, for which there is no equivalent available from one 
of these countries, preference is given to manufacturers with national GMP certifi cation. 
For inpatient medicines, all products tendered should comply with GMP.r  
Prescribing
After a previous failed attempt to introduce generic prescribing, this was fi nally introduced 
in late 2012. All doctors are now required to use generic (international nonproprietary) 
names when prescribing. Audits are conducted at pharmacies to check whether registered 
prescriptions used generic names. At this stage, it is only possible to check prescriptions for 
reimbursed medicines. However, the country is planning to introduce e-prescribing, which will 
facilitate surveillance of prescribing habits for all prescription medicines.
4.3 Innovations in strengthening palliative care policy 
Since 2008, the Republic of Moldova has worked towards implementation of a 
comprehensive policy and regulatory framework for palliative care. Although the Mandatory 
Health Insurance Programme has included palliative care since 2007 (Decree number 1387 of 10 
December 2007), the provision and funding of palliative care was previously fragmented, focused 
mainly on programmes addressing people living with HIV and cancer patients, and mostly funded 
by donors.
In 2008, the Ministry of Health approved a paper entitled Concept of developing palliative care 
services in the Republic of Moldova. The paper defi nes palliative care as an integral part of the 
health system and an inalienable element of the citizens’ right to health care.
In 2009, the Ministry of Health formally approved procedures and rules for the organization of 
palliative care, including the principles and types of palliative care (hospice care, home care, 
mobile care teams, departments in hospitals and outpatient clinics), as well as the criteria for 
assessing patients and determining organizations eligible to provide palliative care, which 
include public and private providers.
At the end of 2010, the Ministry of Health approved national standards for palliative care. This 
document clearly defi nes the rules and procedures for the provision of palliative care services, 
methods and sources of fi nancing, drug provision, coordination, and legal and ethical aspects.
As part of the national standards implementation process, the development of community 
and home care services was included in the Ministry of Health Activity Plan for 2011; additional 
regulatory acts have been approved, which determine the change in the standards for medical 
personnel within the palliative care programme. In addition, payment rates for palliative services 
have been approved, and CNAM has started to contract with governmental and nongovernmental 
organizations for the provision of palliative care.
In 2011, the Ministry of Health adopted a roadmap for the health sector, Accelerating reforms: 
addressing the needs of the health area through investment polices 2012 -2014. This document 
also refl ected palliative care through “revision and improvement of the payment mechanism for 
health services provided by community centres, rehabilitation services, palliative and social care 
services, etc., by applying payment mechanisms per treated case, per assisted case, per visit, etc.”. 
The Methodological Standards on the Use of the Unique  Mandatory Health Insurance Programme 
for 2013, approved by the Ministry of Health in late 2012 (№ 1239/253-A from 10 December 2012) 
determine the procedures for providing services, a package of services for insured persons and 
payment rates for home health services, including palliative care. 
General information on the funding of palliative care services by CNAM since 2011 is summarized 
in Table 9
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In 2005, the emergency hospital in Chisinau began an important transformation to improve their 
capacity to respond to emergency cases. Under a project to regionalize emergency services, 
the hospital was assigned to serve as the coordinator for emergency services in fi ve districts, 
covering a population of 560 000. The hospital operates with a contract from CNAM, which has 
undertaken to improve their capacity signifi cantly. Nearly 30% of all emergency calls are related 
to cardiovascular disease. The Ministry of Health and the hospital management team initiated 
several initiatives that have dramatically improved the emergency response, ranging from 
implementation of clinical protocols for key diseases to the introduction of GPS technology for 
the ambulances. 
Emergency calls come in to the dedicated call centre, which is open 24 hours a day, seven days a 
week. A pre-hospital triage results in only about 25% of patients, who call in, being brought to the 
At this stage, it is too early to speak about tangible improvements in the provision and quality 
of palliative care, because the programme is still in a very early stage of implementation. Further 
work may include strengthening inter-sector coordination and collaboration, and developing co-
fi nancing mechanisms (Ministry of Health, CNAM, Social Protection Fund, donors, etc.) for the 
respective programmes, with monitoring of implementation and evaluation of results. 
It is already evident, however, that the Republic of Moldova has made excellent progress in 
developing a unifi ed strategy and regulatory framework for palliative care. This provides 
the necessary foundations for further work on increasing access and improving the range 
and quality of palliative care in the country.
Potential lessons
Palliative care has been adopted in many CIS countries, but without clearly defi ned criteria for 
the organization and delivery of services and without appropriate mechanisms to designate 
providers and defi ne payment methods. 
In many countries, the development of palliative care is driven mainly by the enthusiasm of 
individuals and public fi gures. The range of assistance is often quite limited (e.g. to patients 
with AIDS or cancer), and it is often practically non-existent in rural areas. Separate programmes 
implemented by NGOs and funded by international organizations are often more successful. 
Funding of these programmes from government sources is often fraught with legal and regulatory 
barriers, especially in the case of contracting private providers, NGOs, professional associations 
and the like. 
The experience of the Republic of Moldova in developing a comprehensive policy and regulations 
for palliative care may be useful to other countries.
Table 9. Funding of palliative services by CNAM, 2011–2013
a Source: Health systems in transition Republic of Moldova, 2012
b Palliative services started to be provided from 01 September 2012. 
  Source of data: CNAM. 
4.4 Innovations in strengthening emergency services
Budget 
allocated to 
palliative 
care (Lei) 
Palliative 
care as % 
of total 
CNAM 
budget
Rate per visit 
for home 
care
(Lei)
Rate per 
bed–day in 
hospice (Lei)
No. of 
providers 
contracted 
by CNAM
No. of 
home 
visits 
conducted
No. of 
bed–
days
2011 925.2 
million
0.03 - 93a (US$ 8) 2 - 5747
2012 2358.6 
million
0.06 69.30 (US$ 6) 214.40  (US$ 
18)
4 1224b 11 000
2013 
(plan)
3902.5 
million
0.01 69.30 (US$ 6) 214.40  (US$ 
18)
10 18 260 12 300
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hospital. Ambulances are equipped with tele-ECG machines with which the ambulance team can 
send the ECG to the emergency hospital for remote consultation. For ambulance teams that do 
not include a physician, the ECG can be read remotely and the emergency hospital calls the team 
to give instructions for treatment and processing of the patient. 
The team has put in place a quality improvement mechanism to continuously monitor all 
emergency-related mortality in the capital and assess the intervening factors. Using the GPS 
technology in the ambulances, the team is able to monitor the response times (call-to-patient, 
call-to-hospital, etc.) by diagnosis for each ambulance, important data to help ensure that 
response is as rapid and eff ective as possible. 
Scaling-up of the system to diff erent regions of the country has started. 
The Moldovan Government has demonstrated its commitment to health system reform. In 
recent years, many important reforms have been implemented, including the introduction of 
the national health insurance company (CNAM), adjustment of the provider payment mechanism 
to improve equity in health resource allocation, and provide incentives for health care providers 
to deliver better services. Recently a DRG system for hospital payment has been set up and this 
year additional incentives have been introduced through a pay-for-performance mechanism, 
to improve the screening and management of key conditions, including core NCDs, at primary 
health care level. The autonomy of providers has also been increased, primary health care has 
been given priority in resource allocation, and their services have been made universally available.
Allocations to health from the state budget are among the highest in the CIS, and effi  cient 
use of funds is therefore a priority if improvements are to be made. The pharmaceutical 
sector is an important area for effi  ciency improvement. Several important policy changes have 
been implemented in recent years, including increased resource allocation for outpatient drugs, 
requiring GMP for public reimbursement and the introduction of mandatory generic prescribing. 
Overall mortality rates in the Republic of Moldova are still comparatively high compared 
with other countries in the region, although they have started to fall. There is a substantial 
gap in life expectancy between the Republic of Moldova and the EU countries. To close this gap, 
it will be essential to control the major NCDs. Both prevention and treatment are important, and 
action needs to be taken at both population and individual service level. 
Major gains can be made through relatively low-cost public health and primary health care 
interventions. These include, among others, strengthening tobacco, alcohol, and dietary polices 
and their implementation, improving detection and treatment of risk factors for cardiovascular 
disease, including hypertension and hyperlipidaemia, strengthening clinical protocols, and 
improving rational prescribing practice through better drug lists and guidelines for prescribing. 
Specifi c recommendations, based on the fi ndings of the assessment mission, are given below.
The starting point – and the greatest opportunity – for the Republic of Moldova to reduce 
mortality, both overall and from NCD, is to reduce the prevalence of major risk factors for NCDs: 
tobacco smoking, harmful  use of alcohol, and unhealthy diet and lifestyles. Ratifi cation of the 
FCTC and the recently approved national alcohol and tobacco programmes are a good start, 
and a series of actions may be considered to build on and strengthen these eff orts. In addition, 
interventions to improve the management of acute conditions, such as AMI and stroke need to 
be strengthened. 
1. Strengthen surveillance and monitoring of key parameters for all the major NCD risk 
factors at local and national levels and defi ne coordination mechanisms for this. Consider 
developing country tailored targets for behaviour risk factors and revise indicators in line 
5. Policy recommendations
5.1 Population Interventions
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The most important opportunities to reduce NCD mortality through individual services lie in 
strengthening primary health care to better manage and treat risk factors for cardiovascular 
disease, and better management of acute episodes, such as heart attack and stroke. 
Population empowerment
1. Evaluate the effi  cacy of the hypertension and diabetes schools.
2. Develop a standardized curriculum for these schools, along with national IEC materials 
for use by participants.
3. Intensify eff orts to make patients aware of new clinical guidelines and the services 
they should receive, including clinical targets and screening recommendations. 
4. Ensure that patient schools are widely promoted and consider ways to provide 
incentives for participation. 
5.2 Individual services
with the respective aspects of the WHO Global Action Plan for the prevention and control 
of noncommunicable diseases 2013-2020 including for example additional indicators, to 
cover areas such as excise duty tax for alcoholic beverages and cigarettes, level of restriction 
on sales promotion, etc. 
2. Consider ways to increase resources for public health services and risk factor reduction, by 
ring-fencing allocations or earmarking. 
3. Strengthen undergraduate, postgraduate and continuing public health education curricula 
for the public health workforce (to include evidence-based public health, biostatistics, 
epidemiology of NCDs and their risks factors, health promotion and disease prevention, 
public health policy development, monitoring and evaluation). 
4. Strengthen coordination in the area of health lifestyles and diet and link to an action plan, 
monitoring and resourcing. 
5. Intensify eff orts to harmonize tobacco taxation policies with those of the European Union 
by 2025 or earlier. 
6. Clarify and strengthen enforcement modalities for alcohol, tobacco and diet laws and 
regulation and as appropriate address needed reform in legislation. 
7. Look for opportunities to learn from other countries that have made good progress in 
reducing risk factors, e.g. Turkey on tobacco control. 
8. Increase the capacity of the National Centre of Public Health to develop eff ective, evidence-
based materials for information, education and communication (IEC) on main NCDs risk 
factors and control for diff erent target groups.  
9. Strengthen mechanisms for ensuring that approved IEC materials at the various levels 
refl ect latest evidence and best practice to reach diff erent target groups.
10. Base NCD communication strategies on assessments of population knowledge, attitudes 
and practices (KAP). Key individuals from the NCPH should be trained to conduct and 
interpret KAP surveys, and in social marketing to maximize the eff ectiveness and effi  ciency 
of population education campaigns. 
11. Set up a working group involving key stakeholders (e.g. Ministry of Health, CNAM, NCPH) 
to ensure coordination of population campaigns, including prioritization of topics, 
development of IEC materials, and message strategies. Given the detrimental eff ect of 
late presentation for care for AMI and stroke, population messages aimed at reducing the 
symptom-to-hospital time should be considered among the priorities.
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Eff ective models of service delivery
1. Accelerate the process of revising the clinical protocols for priority NCD topics 
(hypertension, type 2 diabetes, asthma, COPD), to remove the requirement for family doctors 
to refer patients to specialists for confi rmation of diagnosis and routine follow-up. Remove 
the restriction that prevents family doctors from ordering glycosylated haemoglobin tests.
2. Make nurse check-in examinations (with measurement of blood pressure, weight, etc.) 
mandatory for all clinic patients. Encourage nurses to play a more active role in risk factor 
screening (document in chart) and individual patient counselling.
3. Shift the role of specialists away from providing care for patients with uncomplicated 
disease towards more involvement in supporting primary care providers in adhering 
to standards (audits, education) and consulting on patients with complications or diffi  cult-
to-control disease.
4. Shift responsibility for leading patient education classes (diabetes and hypertension 
schools) to nurses.
5. Continue eff orts to strengthen palliative care, including intersectoral coordination and 
co-fi nancing mechanisms (Ministry of Health, CNAM, Social Protection Fund, donors, etc.) 
for the palliative programmes, monitoring their implementation and evaluating results. 
Economies of scale and specialization 
1. Give priority to developing regionalization strategies for NCDs (management of 
myocardial infarction, stroke, cancer screening, and cancer treatment), taking into account 
issues of economies of scale and access. 
2. Decentralize thrombolytic therapy for acute myocardial infarction to the district hospital 
level. Support rayon-level cardiologists, critical care specialists, and therapists (involved in 
the primary evaluation and treatment of patients with myocardial infarction) through brief 
(2–3 weeks) clinical mentoring followed by regular monitoring and support.
3. Establish clear referral policies for patients with stroke and AMI, including criteria 
for rationalization of high-cost, high-technology interventions, such as coronary artery 
stenting for myocardial infarction and thrombolytic therapy for stroke.
4. Establish a working group composed of oncologists, gynaecologists, and family doctors 
to explore alternative screening methods for cervical cancer (e.g. visual inspection 
with acetic acid), which may be more appropriate in the Moldovan environment, given the 
shortage of cytologists.  
Human resources
1. Develop a strategy to increase the capacity of mid-level providers (feldshers and nurses) 
working in rural health facilities to take a more active role in detecting and managing 
low- and medium-risk patients with hypertension or diabetes, and patients with mild 
persistent asthma.  This should involve defi ning the scope of services, specifying clear 
referral criteria for each illness, and developing straightforward, algorithm-based clinical 
protocols. (WHO has published clinical algorithms for managing patients with elevated CVD 
risk appropriate for non-physician health care providers.28) Nursing school curricula and 
continuing education modules should be revised accordingly to ensure that both nurses 
and feldshers entering the workforce and those already practising have the necessary core 
competencies. 
2. Strengthen undergraduate, residency, and continuing medical education curricula 
for family doctors to ensure that they feel confi dent in their ability to independently 
detect and manage the majority of patients with noncommunicable disease. 
3. Continue to explore innovative methods to recruit both family doctors and specialists 
to rural areas. Benefi ts off ered in current programmes to motivate providers to work in 
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rural areas are adequate to attract nurses, but not physicians. A detailed assessment of 
issues related to the high emigration rates of health care workers and the low percentage 
of medical school graduates entering the work force was beyond the scope of this mission, 
but is included in a WHO/World Bank study, which is scheduled to be published later this 
year and which can be used to inform policy decisions.
Access to quality medicines for NCDs
A. Aff ordability:
1. Improving rational selection, prescribing, dispensing and use of medicines: 
a. Finalise the revision of the national EML based on the latest WHO EML with adaptations 
to the country’s epidemiological profi le. Use the national EML for reimbursement 
decisions and ensure both, the EML and the reimbursement list, are linked to evidence-
based national treatment protocols.
b. Train existing doctors in rational prescribing but most importantly include rational 
prescribing in the medical curriculum.
c. Revise the mark-up structure to reduce the fi nancial incentive for pharmacists to 
dispense higher cost drugs over less expensive alternatives. Further, consider the 
introduction of a dispensing fee to reward the pharmacist’s counselling services and 
a small fi nancial incentive for dispensing non-branded generics that cost no more 
than the maximum reimbursed price reimbursed by CNAM (e.g. Australia, Switzerland). 
d. Leverage on existing data to monitoring prescribing patterns and use this 
information to target eff orts in improving rational prescribing.
2. Strengthening the existing price monitoring system:  
a. Revise the list of drugs monitored to the most important from a public health 
perspective (i.e. national essential medicines). 
b. Include analysis of aff ordability for diff erent income quintiles  
c. Monitor consumption patterns and the market shares of originator, branded generic 
and generic for individual drugs.
d. Use these data for policy decisions (e.g. to guide decision on inclusion in the 
reimbursement and percentage reimbursement).
3. Revising pricing and reimbursement regulations and consider the introduction of: 
a. A clawback system  to share savings accrued from discount between the supply 
chain and CNAM (medium term). The system should be designed to maintain 
the incentive for the supply chain to negotiate discounts with manufacturers and 
wholesalers yet at the same time share part of the savings with CNAM. 
b. A diff erential mark-up system with lower mark-ups for medicines reimbursed by 
CNAM and a regressive mark-up system were higher prices are associated with lower 
mark-ups (medium). Consider the introduction of a dispensing fee to compensate for 
lower mark-ups and a small fi nancial incentive to dispense lowest cost generic drugs 
(medium).
c. A tendering system for selected medicines (purchased in high volume) from the 
reimbursement list should be tested. This could be easily achieved given existing 
country’s experience in conducting national tenders for inpatient medicines. (short/
medium).
The saving generated by these reforms should be used to expand the list of generics reimbursed 
and the level of reimbursement.
Integrating evidence into practice
1. Consider adopting a methodology for development of full clinical practice guidelines 
that includes grading of clinical recommendations and levels of evidence. Developing 
such guidelines is a much lengthier process than adapting existing international guidelines 
into abbreviated clinical protocols; it should be done in parallel with the existing practice of 
protocol development rather than replacing it.
2. Have draft clinical protocols and practice guidelines reviewed by an international 
consultant before submitting them for review by the local expert committee for 
Ministry of Health approval. Such reviews have been found to be very eff ective in 
other countries where the clinical protocol development process is relatively new, since it 
ensures that evidence is appropriately interpreted and can detect subtle infl uences of the 
pharmaceutical industry.
3. In medical schools and institutes responsible for postgraduate training and continuing 
medical education, there should be a formalized system whereby department heads 
are required at regular intervals to provide evidence of how training materials are 
updated to refl ect new clinical guidelines. The “language” of evidence-based medicine 
should be evident in all clinical lectures and modules. 
4. To address the frequent prescription of non-evidence-based drugs in hospitals, 
consider incorporating lists of frequently used but non-evidence-based medications into 
clinical protocols along with performance indicators related to their use, facilitating quality 
assurance reviews of both ambulatory and inpatient care that focus on ending ineff ective 
(and possibly harmful) practices that increase out-of-pocket expenditures for patients.
Creating the right incentive systems
1. In order to refi ne the capitation model, consider an analysis of the use of primary 
health care by age group and sex.
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B. Quality of medicines:
1. A post-marketing surveillance system is urgently needed to ensure continuous 
monitoring of the quality of medicines (short/medium term). This monitoring 
system could be paper based in the beginning with the aim to move on the longer term 
to an electronic system. To ensure its impact, it is essential that the necessary funds and 
human capacity are made available for the development and maintenance (particularly 
in terms of IT and analytical capacity) of the system. Beyond data collection, doctor’s 
awareness needs to be raised about the importance of post-marketing surveillance as 
their collaboration will be vital for the proper functioning of such system. 
C. Reimbursement list:
1. The process of compilation of the reimbursement list needs to be improved. There 
should be a clear link between the national EML, the reimbursement list and 
clinical protocols. All the three should only include proved cost-eff ective drugs 
addressing diseases of public health relevance in the country.
2. A formal written process for updating the EML should be developed following 
international best practice (e.g. see Swedish wise list ).
3. Pharmacies need to be given suffi  cient time (at least one week) to adjust their 
reimbursement prices once a new list is approved. Each time a new reimbursement list 
is developed, information documents summarising the main changes relevant to 
patients and should be developed and made available in all pharmacies across the 
country and primary health care practices.   
5.3 Accountability and use of information
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2. The pay-for-performance indicators are mainly aimed at monitoring the process of 
interventions. This is good but in the long term, it may be necessary to include indicators 
that refl ect the impact or outcome achieved through the implementation of key processes. 
3. Determine the frequency of, and criteria for, revision of indicators and targets. 
4. Consider reducing the frequency of the pay-for-performance reviews (currently 
monthly) in order to reduce the reporting burden.
5. Continue to expand the DRG system, defi ning transition phases and criteria for each 
phase, and introducing a system to monitor hospital performance.
Creating adequate information solutions
1. The reforms currently under way in the health system of the Republic of Moldova necessitate 
new standards for the quality, reliability and effi  ciency of medical information. The 
Ministry of Health should intensify planned works to create and implement a unifi ed 
e-health system to optimize the collection, analysis, dissemination and strategic use 
of information by all actors in the health system.
2. Improve the use of the existing DRG and emergency databases to ensure that available 
data are used:
• at the national level for strategic planning (BBP, budget planning and resource allocation, 
setting priorities for drug  purchasing, etc.);
• in management, for monitoring the quality of health services at the health provider 
level and in the system as a whole;
• to design and implement simple performance monitoring systems at the service-
delivery level.
3. Develop disease-specifi c ambulatory fl ow sheets that serve as a reminder for 
screening and summarize essential fi ndings. The current ambulatory health record does 
not contain health summaries or fl ow sheets that contribute to the assessment of NCD 
risk factors, so time-consuming searches through visit notes are required to fi nd essential 
information, such as smoking status, alcohol use, screening results, and even blood pressure 
results. Many facilities have designed their own fl ow sheets to summarize risk factors that 
are required for pay-for-performance reporting, and these are likely to contribute positively 
to management of chronic NCDs.  
4. Since the implementation of full electronic outpatient records in primary health care is a 
long-term process, it is advisable to start with the development of electronic registers 
of patients with chronic cardiovascular disease, cancer, diabetes or asthma.
• The registers should be connected to the CNAM population database, and have the 
same format and standard set of information, including not only the personal details of 
the patient (which now exist on paper), but also a consistent set of clinical information 
(prescriptions, follow-up, test results, etc.). This will allow managers and providers to 
assess the adequacy of case management according to clinical protocols and provide 
insight into the results of treatment.
• Registers of chronic patients will allow personalized monitoring of case management 
according to treatment protocols, monitoring of prescriptions and drug scheduling, 
as well as providing a standard package of aggregated clinical information by health 
facility and across the system as a whole.
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Annex 1. Data sources and methods 
Data sources for this report include demographic and health-related indicators found in the WHO 
European Health for All database (January 2013 update).a The majority of the data cover 1980–90 
to 2009–10. The indicators selected for analysis refl ect expert recommendations and practical 
considerations of what evidence was available. 
Consideration has been given to estimates and projections of data reported annually by the 53 
Member States of the WHO European Region; country subgroups have been applied to highlight 
regional trends. These subgroups refl ect those defi ned in the Health for All database, as outlined 
below.
• EU-15: the 15 Member States that belonged to the European Union (EU) before 1 May 2004: 
Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, 
the Netherlands, Portugal, Spain, Sweden and the United Kingdom. 
• EU-12: the 12 new Member States that joined the EU in May 2004 or in January 2007: 
Bulgaria, Cyprus, the Czech Republic, Estonia, Hungary, Latvia, Lithuania, Malta, Poland, 
Romania, Slovakia and Slovenia. 
• CIS (Commonwealth of Independent States until 2006): Armenia, Azerbaijan, Belarus, 
Georgia, Kazakhstan, Kyrgyzstan, the Republic of Moldova, the Russian Federation, 
Tajikistan, Turkmenistan, Ukraine and Uzbekistan. 
Countries in the WHO European Region but not included in these groups are: Albania, Andorra, 
Bosnia and Herzegovina, Croatia, Iceland, Israel, Monaco, Montenegro, Norway, San Marino, 
Serbia, Switzerland, the former Yugoslav Republic of Macedonia and Turkey. 
For medicines, data sources included the WHO Global Health Expenditure Database, the WHO/
HAI survey on prices and availability of medicines in the Republic of Moldova (2011), national 
data from the household budget survey and data provided by the national insurance company 
(CNAM). 
a WHO Regional Offi  ce for Europe. Health for all database. (Jan 2013 update). Copenhagen; 2013 (http://data.euro.who.
int/hfadb/).
49
Tobacco control core 
service coverage
Score for Republic 
of Moldova
Limited Moderate Extensive
Range of 
anti-smoking 
interventions (FCTC)
Limited Prevalence among 
adults greater than 
30%
Prevalence among 
adults between 18% 
and 30%
Prevalence among adults 
less than 18%
Raise tobacco taxes Limited Tax is less than 25% 
of retail price
Tax is between 25% and 
75% of retail price
Tax is greater than 75% of 
retail price
Smoke-free  
environments
Limited   100% smoke-
free environment 
enforced in schools 
and hospitals only
100% smoke free 
environment enforced 
in hospitals, schools, 
universities, public 
transport and 
workplaces
100% smoke-free 
environment enforced in 
all public places, including 
hospitality sector
Warnings of dangers 
of tobacco and 
smoke
Moderate Warning labels 
required on tobacco 
products, size not 
specifi ed
Warning labels on all 
tobacco products at 
least 30% of package 
size (front and back)
Warning labels greater 
than 50% of package size 
(front and back), with 
pictures (standardized 
packaging)
Bans on advertising, 
promotion, 
sponsorship
Limited No ban or ban on 
national TV, radio 
and print
Ban on direct and 
indirect advertising and 
promotion
Ban on all advertising 
and promotion, including 
at points of sale, with 
eff ective enforcement
Quit lines and 
nicotine replacement 
therapy (NRT) (This is 
an additional criteria 
not in Global Action 
Plan)
Limited No quit lines or 
government-funded 
cessation services, 
but NRTs allowed 
and available for full 
pay by individuals
Quit lines, government-
funded cessation 
services are available 
(possibly for payment). 
NRT available for full 
pay.
Toll-free quit line, 
cessation services and 
NRTs are available and and 
aff ordable (covered at least 
partially)
Annex 2. Criteria for scoring coverage 
of population interventions
Criteria for scoring tobacco- and alcohol-related interventions 
and score for the Republic of Moldova
50
Alcohol control core 
service coverage
Score for Republic 
of Moldova
Limited Moderate Extensive
Interventions to 
prevent harmful 
alcohol use
Raise taxes on alcohol Limited Alcohol taxes follow 
price index
Alcohol taxes follow 
price index; special taxes 
on products attractive to 
young people
Alcohol taxes follow 
price index and related 
to alcohol content; 
special taxes on products 
attractive to young people
Restrictions, bans 
on advertising/
promotion 
Limited   Regulatory 
frameworks exist 
to regulate content 
and volume of 
alcohol marketing
Regulatory frameworks 
exist to regulate content 
and volume of alcohol 
marketing including 
direct and indirect 
marketing as well as 
sponsorship
Full ban on alcohol 
marketing of any kind 
Restrictions on 
availability of retailed 
alcohol
Moderate Regulatory 
frameworks on 
serving of alcohol 
in governmental 
and educational 
institutions
Regulatory frameworks 
on serving of alcohol 
in governmental 
institutions and ban 
on serving alcohol in 
educational institutions
All governmental and 
educational institutions 
free of alcohol
Minimum purchase 
age regulation and 
enforcement  (This 
is an additional 
criterion not in Global 
Action Plan)
Limited Minimum purchase 
age of 18 years for 
all alcohol products 
Minimum age of 18 
years for all alcohol 
products and eff ective 
enforcement
Minimum age of 18 years 
for all alcohol products and 
eff ective enforcement; loss 
of license to sell alcohol if 
found breaking the law
Allowed blood 
alcohol level for 
driving(This is an 
additional criterion 
not in Global Action 
Plan)
Limited Blood alcohol 
content (BAC) 
maximum of 0.5 g/l
BAC to be a maximum 
of 0.5 g/l and zero for 
novice and professional 
drivers
BAC to be a maximum of 
0.2 g/l and zero for novice 
and professional drivers
Multisectoral policy 
development (This 
is an additional 
criterion not in Global 
Action Plan)
Moderate Multisectoral 
national strategy on 
alcohol policy
Multisectoral national 
strategy and a 
coordinating council on 
alcohol policy
Multisectoral national 
strategy and a 
coordinating council on 
alcohol policy, plus an 
adequately resourced 
nongovernmental sector, 
free of potential confl ict 
of interest with the public 
health interest
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Criteria for scoring diet and physical activity-related 
interventions and score for the Republic of Moldova 
Alcohol control core 
service coverage
Score for Republic 
of Moldova
Limited Moderate Extensive
Interventions to 
improve diet and 
physical activity
Prevalence 
of children/
adults who are 
overweight or 
obese is greater 
or equal to 30%
Prevalence of 
children/adults who 
are overweight or 
obese is 20–30%
Prevalence of children/
adults  who are 
overweight or obese is 
lower than 20%
Reduce salt intake 
and salt content in 
foods
No data available Not more than 10% 
reduction of salt 
intake has been 
registered in the 
past 10 years  
Salt intake has been 
reduced by at least 10% 
in the past 10 years
Salt intake has been 
reduced by more than 10% 
in the past 10 years
Virtually eliminate 
trans-fatty acids from 
the diet
Limited   There is no evidence 
that trans-fats have 
been signifi cantly 
reduced in the diet 
Trans-fats have been 
reduced in some food 
categories and industry 
operators but it is not 
mainstreamed 
Trans-fats have been 
virtually eliminated from 
the food chain through 
government legislation 
and/or self-regulation
Reduce free sugar 
intake (This is an 
additional criterion 
not in Global Action 
Plan)
Limited The aim to reduce 
the intake of free 
sugars is mentioned 
in policy documents 
but no action has 
been taken
The reduction of intake 
of free sugars by 5% is 
mentioned and partially 
achieved in food 
categories 
The reduction of intake 
of free sugars by 5% is 
monitored with a focus 
on sugar-sweetened 
beverages
Intake of fruit and 
vegetables (This is an 
additional criterion 
not in Global Action 
Plan)
Limited The aim to increase 
consumption of 
fruit and vegetables 
is mentioned but 
no monitoring data 
have been collected 
to support it.
The aim to increase 
consumption of fruit 
and vegetables is in 
line with the WHO/FAO 
recommendations of 
at least 400 g/day and 
some initiatives exist 
The aim to increase 
consumption of fruit 
and vegetables is in 
line with the WHO/FAO 
recommendations of 
at least 400 g/day with 
population initiatives, 
incentives to increase 
availability, aff ordability 
and accessibility
Reduce marketing  
of food and non-
alcoholic beverages 
to children (This is an 
additional criterion 
not in Global Action 
Plan)
Moderate Marketing of foods 
and beverages to 
children is noted as 
a problem but has 
not been translated 
into government-
led initiatives. 
WHO set of 
recommendations on 
marketing have been 
acknowledged and 
steps have been taken in 
self-regulatory approach 
to reduce marketing 
pressure on children 
WHO recommendations 
on marketing and 
the Implementation 
Framework on Marketing 
are followed consistently, 
including mechanism for 
monitoring  
Promote awareness 
about diet and 
activity
Not assessed Workforce 
development 
for nutrition and 
physical activity 
does not exist;  
nutrition and 
physical activity not 
a priority element in 
primary care  
Some workforce 
development for 
nutrition and physical 
activity; nutrition and 
physical activity starting 
to be considered a 
priority element in 
primary care  
Workforce development 
for nutrition and physical 
activity exists and nutrition 
and physical activity a 
priority element in primary 
care   
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Annex 3. Features of the Moldovan 
health system that aff ect delivery of 
services for NCD control
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Screening for 
cervical  cancer 
and diagnosis  
of precancerous 
lesions
2 3 2 1 1 0 0 3 1 3 1 17
Early case-
fi nding for 
breast cancer 
and diagnosis at 
all stages
2 3 2 2 1 0 0 3 1 3 0 17
Risk factor 
detection 
and risk 
stratifi cation at 
primary health 
care level
3 2 1 0 1 0 1 2 2 3 0 15
Eff ective 
management of 
hypertension, 
diabetes, lipids
2 2 1 0 1 2 2 2 2 3 0 17
Diabetes 
management 2 3 1 0 1 1 1 2 2 3 0 16
Rapid response 
and hospital-
level care for 
AMI, stroke
2 2 0 2 2 2 1 2 2 3 0 18
Total 13 15 7 5 7 5 5 14 10 18 1
Table A3.1.  Overall scorecard of Moldovan health systema 
0=minor negative impact
1=moderate negative impact
2=major negative impact
3=persistent major negative impact
a For details, see Tables A3.2 to A3.6.
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Table A 3.2 Health system challenges and opportunities that aff ect screening for cervical cancer and 
treatment of precancerous lesions
Health system 
challenges and 
opportunities
Level Findings 
Patient engagement 2
Limited self-referral for routine Pap smears; limited awareness of recommended 
screening ages and intervals. At one site, only 32% of eligible women had cervical cancer 
screening. Doctors note that it is diffi  cult to convince women to agree to screening.
Service delivery 
models 3
Family doctors not performing Pap smears (refer to nurse-midwife). Smears sent to 
central level, resulting in long delays. Most women with cytological abnormalities 
referred to national oncology centre. System of biannual Pap smears not optimal for 
cervical cancer screening given limitations in human resources. Absence of external 
quality assurance of cytology laboratories.
Coordination of care 2 Functioning adequately in large central territorial medical associations where staffi  ng is optimal, but diffi  culties with outsourcing cytology in rural areas.
Economies of scale 1 Human resource issues not conducive to decentralization of cytology services. 
Integration of 
evidence-based 
medicine
1 Inappropriate methods being used for smear preparation (specimens allowed to air-dry; Romanovski-Giemsa stain used instead of Papanicolaou). 
NCD drug 
availability 0
Payment system 0
Human resource 
problems 3
Family doctors inadequately trained to perform Pap smears and interpret cytology 
reports. High rates of inadequate smears from periphery suggest need for more 
eff ective training programmes. Lack of cytologists has led to centralization of services, 
overloading of cytologists, and long delays in getting results to primary care level.
Management 1
Incorporation of cervical cytology coverage into pay-for-performance system of NHIC 
has stimulated primary care level to conduct internal audits, but used only to assess 
coverage, not quality.
Health information 
system 3
No electronic system to track at-risk population, send patient reminders, or track 
screening coverage and quality.
Resistance  to 
change 1
No apparent  initiative to explore alternative, evidence-based methods for prevention of 
cervical cancer that are more appropriate in the current human resource situation.
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Table A3.3. Health system challenges and opportunities that prevent detection of CVD risk factors 
and risk stratifi cation at primary level
Health system 
challenges and 
opportunities
Level Findings 
Patient engagement 3 Presumed low awareness among population of silent nature of hypertension and need for blood pressure screening 
Service delivery 
models 2
Primary health care providers not diagnosing and classifying majority of patients with 
hypertension or type 2 diabetes. Ineffi  cient use of specialists; ineffi  cient use of nurses. 
Most primary health care facilities have nurse check-in room but only small percentage 
of clinic patients go through (those who request screening or those over 45 who have 
not been screened in the past year). International Diabetes Federation estimates that 
36% of patients with type 2 diabetes in the Republic of Moldova are unaware of their 
diseasea
Coordination of care 1
Good communication between specialists and primary care providers at family medicine 
centres and some health centres (document in same record); records not consistently 
available when patients referred between levels.
Economies of scale 0 Not relevant 
Integration of 
evidence-based 
medicine
1
High quality clinical protocols covering screening, diagnosis, and risk stratifi cation of 
CVD and diabetes. Clinical protocols widely available and used. Some discrepancies 
between protocol content, national policies on health maintenance visits, and pay-for-
performance indicators.
NCD drug 
availability 0
Payment system 1
Current pay-for-performance indicators may need some strengthening and may lead 
to overprovision of screening services. Survey fi ndings suggest that informal payments 
for ambulatory care may be limiting access to health services (37% of patients made 
informal payments for outpatient care; 30% did not access health care when medical 
attention was needed).b
Human resource 
problems 2
Shortage of primary care providers and advanced age of primary health care workforce; 
inadequate scope of services of mid-level providers in health offi  ces. Low rates of asthma 
registration (0.3% in one site visited) probably related to limited provider knowledge of 
various presenting symptoms.c
Management 2
Internal quality monitoring system limited to audits to collect data for pay-for-
performance indicators.  Few eff orts by management to encourage health care workers 
to increase case-fi nding of NCDs currently under-registered. 
Health information 
system 3
Existing system is primarily paper-based and it is diffi  cult to generate provider-level 
disease-specifi c reports. No electronic tracking of NCD risk factors.
Resistance  to 
change 0
a http://www.idf.org/atlasmap/atlasmap, 2012 data (accessed 09 June 2013).
b Health In Time of Transition, Policy Brief: Access,  New Research:  Access to health care in Republic of Moldova. April 2013. 
c The prevalence of asthma among children in neighbouring Romania is near 9% (The Global Asthma Report 2011. Paris, 
France: The International Union Against Tuberculosis and Lung Disease, 2011).
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Table A3.4. Health system  challenges and opportunities for NCD control.
Health system 
challenges and 
opportunities
Level Findings 
Patient engagement 2
Presumed low awareness among population of benefi ts of primary prevention and 
asymptomatic nature of hypertension; misperceptions among population  regarding 
chronic medication use; limited impact of systems to support patient adherence. Schools 
for hypertensive patients poorly attended and patient education material limited.
Service delivery 
models 2
National protocols require all hypertensive and patients with diabetes to be referred to 
specialists (cardiologist or endocrinologist) for confi rmation of diagnosis and periodic 
consultation, rather than only high-risk patients or those not responding to therapy. 
Limited use of mid-level personnel in periodic risk assessment and patient education 
(e.g. cardiologists lead hypertension schools).
Coordination of care 1
Good communication between specialists and primary care providers at family medicine 
centres and health centres; input from specialists in the private sector not documented 
in ambulatory record. 
Economies of scale 0 Not relevant. 
Integration of 
evidence-based 
medicine
1
Doctors routinely use protocol summaries designed for primary level; good link with 
pay-for-performance indicators.  Some recommendations in clinical protocols and pay-
for-performance plan not based on strong evidence. Statins not prescribed for primary 
prevention in high-risk patients and only small fraction who need secondary prevention. 
Frequent use of non-evidence-based medications, such as hepatoprotectors and 
cardioprotectors. Almost all medications listed in medical record, including acetylsalicylic 
acid, are listed by trade name.
NCD drug 
availability 2
Statins are expensive, and not in drug reimbursement list. Branded drugs are commonly 
prescribed; pharmaceutical industry has undue infl uence.
Payment system 2 Pay-for-performance system focused more on preventive service coverage rather than quality of management.
Human resource 
problems 2
Shortage of primary care providers in periphery; inadequate scope of services of mid-
level providers in family doctor offi  ces and health offi  ces.  
Management 2
Internal quality monitoring system almost exclusively focused on audits required for 
pay-for-performance programme. No clear system linking facility goals and plans to 
internal quality audits, with exception of some territorial medical associations facilities in 
Chisinau.
Health information 
system 3
Ambulatory records do not facilitate tracking of vital NCD data (risk factors, laboratory 
results) needed for treatment decisions. Facilities are designing their own disease-
specifi c fl ow sheets.
Resistance  to 
change 0
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Health system 
challenges and 
opportunities
Level Findings 
Patient engagement 3
Eff ectiveness of diabetes schools limited by low utilization, lack of patient 
education materials and inadequate staffi  ng. Limited awareness among patients 
of recommendations on screening for complications. Limited capacity to provide 
close support to patients or to individualize targets for glycaemic control, exercise 
programmes and dietary recommendations.
Service delivery 
models 1
Over-reliance on endocrinologists for management of patients not requiring insulin. 
Even in Chisinau, with high staffi  ng levels of specialists, waiting time can be one 
week. Currently, only endocrinologists allowed to order glycosylated haemoglobin 
test. Family doctors rarely start oral medications without consulting endocrinologist. 
Underutilization of mid-level providers for screening for complications and 
patient education, although in some Chisinau facilities, nurses check chart to see if 
recommended screenings and consultations have been completed.
Coordination of care 1
No problem where specialists and primary care personnel share facility, but some issues 
when patients are referred to specialists at higher level (provider choice; wait times; 
distance; information sharing).
Economies of scale 0
Integration of 
evidence-based 
medicine
1
Evidence-based protocols in use. ACE inhibitors usually used to manage hypertension in 
people with diabetes. Statins rarely used for primary or secondary prevention of CVD in 
people with diabetes. 
NCD drug 
availability 1
Metformin and oral sulfonylureas provided free to patients with diabetes through CNAM 
drug reimbursement plan. Antihypertensives available at 50% discount; statins not 
discounted.
Payment system 1 Current pay-for-performance programme focused on disease detection rather than quality of management.
Human resource 
problems 2
Low staffi  ng levels of endocrinologists (e.g. one site visited had one ¼-time 
endocrinologist for population of 76 000). Low staffi  ng levels of family doctors (same site 
had only 47% staffi  ng of family doctors). Primary care personnel not confi dent in ability 
to manage patients with type 2 diabetes not requiring insulin (about 80% of practising 
family doctors completed 6-month retraining rather than 3-year residency). Mid-level 
providers not trained to play active role in educating patients with diabetes. 
Management 2
Internal quality monitoring system almost exclusively focused on audits required for pay-
for-performance programme. No clear system linking facility goals and plans to internal 
quality audits. Managers not promoting or requiring more rational use of specialists. 
Health information 
system 3
Ambulatory record format does not facilitate tracking of data needed to manage 
patients with diabetes. No diabetes-specifi c management fl ow sheet being used.  Lack of 
electronic register and health information system makes it diffi  cult to generate provider-
specifi c and disease-specifi c reports for quality monitoring. 
Resistance  to 
change 0
Table A3.5  Health system challenges and opportunities that prevent eff ective management of 
diabetes
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Health system 
challenges and 
opportunities
Level Findings 
Patient engagement 2
Long delays in seeking care for symptoms of AMI and stroke. No public campaigns to 
raise awareness of need for rapid medical attention; “wait and see” mentality. Providers 
see patients as becoming more demanding, less tolerant.
Service delivery 
models 2
Emergency response system well organized and well equipped. Higher-level 
interventions could be provided at pre-hospital level, even where ambulances are staff ed 
by mid-level providers. Very limited critical services off ered in admission department of 
hospitals; not using emergency department model. Admission department coverage at 
night often by providers without special training in managing ACS, strokes. Overuse of 
hospitalization for treatment of hypertension.
Coordination of care 0 Good communication between ambulance services and hospital for critical patients.
Economies of scale 2 Need for clear referral criteria for AMI patients between rayon, oblast, and tertiary hospitals. Thrombolytic therapy not available at regional or district hospitals.
Integration of 
evidence-based 
medicine
2
Good quality clinical protocols being used, but no visible eff orts to motivate doctors 
to stop prescribing non-evidence-based medicines, which aff ect hospital budget and 
patient OOP expenditures. 
NCD drug 
availability 2 Limited availability of thrombolytics at district hospital level.
Payment system 1 No disincentive to hospitalize patients with asymptomatic severe hypertension.
Human resource 
problems 2
Management 2
No clear setting of priorities, targets, and plans connected with internal audits. Internal 
audits focus on utilization data (e.g. average length of stay) rather than content of care. 
Not using existing DRG database to analyse quality gaps. 
Health information 
system 3
Limited quality data in DRG database; vast majority of health information system is 
paper-based and not conducive to generating reports on quality indicators.
Resistance  to 
change 0
Table A3.6 Health system challenges and opportunities that prevent rapid response and delivery of 
hospital-level core interventions for AMI and stroke
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Annex 4. Aff ordability of medicines 
for NCDs included in the 
reimbursement list
This analysis is based on data provided by CNAM (total expenditure and total reimbursement), 
household budget surveys (income quintiles) and reimbursement lists for medicines. *Data for 
2013 include only January-April.
In the following fi gures, each column in a cluster represents a diff erent year (2008, 2010, 2012 
and January to April 2013 if available), each cluster of columns refers to a diff erent medicine and 
strength (e.g. spironolactone 25 mg, lisinopril 2.5 mg, etc.). The columns’ unit is days of wages 
needed to purchase one month of treatment (left hand y-axis) and the stacked parts (shown in 
diff erent colours) show the days of wages needed for diff erent income quintiles (1st-5th income 
quintile). The red diamonds show the percentage of a medicine’s maximum reimbursement price 
which is reimbursed by CNAM (right-hand y-axis). The red bar represents the frontier between 
what is considered to be aff ordable (according to the WHO/HAI defi nition this is less than one 
day of wage of the lowest paid public sector worker) and what is not considered to be aff ordable 
(more than one day of wage of lowest paid public sector worker). In the fi gures below the focus 
is not on wages for the lowest paid worker but on wages for diff erent income quintiles although 
the lowest paid public sector worker’s wage (Lei 20 (US$ 1.7) in 2011) is very close to the wage of 
the 1st income quintile (i.e. the poorest, Lei  18/day in 2012).
Medicines were ordered of increasing aff ordability (less days of wage needed to purchase one 
month of treatment for a chronic condition) on the three diff erent graphs.
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